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ABSTRACT 
Sleep-Disordered Breathing in Children and Adolescents with 
Systemic Lupus Erythematosus and its 
Association with Executive Functioning 
Jennifer Ayala Badgley, M.S. 
Douglas L. Chute, Ph.D. 
 
 
The relationship between sleep-disordered breathing and executive functioning in 
children and adolescents with Systemic Lupus Erythematosus (SLE) has not been well-
studied, despite literature referring to sleep problems in individuals with SLE.  The goals 
of this study were to examine whether sleep-disordered breathing was more prevalent in 
children and adolescents with SLE compared to controls, whether there was an 
association between sleep-disordered breathing and executive functioning, and whether 
certain risk factors moderated or mediated this relationship.  
The SLE group consisted of 22 participants whose parents completed the study 
questionnaires (M age = 15.5, SD = 2.70, range = 9 - 18) and of which 17 completed the 
cognitive testing.  Twenty-four controls from an attempted demographically matched 
population completed a subset of the questionnaires (M age = 14.2, SD = 1.96, range = 9 
- 17).  Parents of those with and without SLE completed the Sleep Disorders Inventory 
for Students (SDIS).  Parents of those with SLE also completed the Behavior Rating 
Inventory of Executive Function (BRIEF) and Depression and Anxiety in Youth Scale 
(DAYS).  Participants with SLE completed the Delis-Kaplan Executive Function System 
Trail Making and Verbal Fluency tests and the Wechsler Intelligence Scale for Children-
IV/Wechsler Adult Intelligence Scale-III Digit Span test.  Disease activity and disease 
severity variables were collected by chart review. 
xi 
 
Results from an independent samples t-test indicated that the SLE sample did not 
exhibit more sleep-disordered breathing symptoms than controls.  For the SLE group, 
correlation analyses indicated that sleep-disordered breathing symptoms were positively 
associated with the BRIEF Global Executive Composite score.  Multiple regression 
analyses to determine moderation and mediation in the relationship between sleep-
disordered breathing and executive dysfunction were not conducted because of a small 
sample size. 
This study suggests that sleep-disordered breathing is not a major health concern 
for children and adolescents with SLE, but those with more symptoms of sleep-
disordered breathing may exhibit more executive functioning difficulties.  This study also 
suggests that the BRIEF, SDIS, and DAYS questionnaires may be useful screening 
measures for use with this population.  Given several methodological limitations, 
findings are preliminary.  Further research is needed that incorporates larger samples. 
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CHAPTER 1: INTRODUCTION 
 
Systemic lupus erythematosus (SLE) is a chronic inflammatory multi-system 
autoimmune disease (Jump et al., 2005; McGhee, Kickingbird, & Jarvis, 2004).  
Immunoregulatory proteins are thought to regulate this inflammation process in SLE 
(Gabay et al., 1997; Lacki, Samborsi, & Mackiewicz, 1997).  Similar immunoregulatory 
proteins regulate the inflammation process in sleep-disordered breathing (Alberti et al., 
2003; Tauman, Ivanenko, OBrien, & Gozal, 2004).  Despite this knowledge, scant 
research has investigated sleep-disordered breathing in detail in SLE (Cruz et al., 2007; 
Valencia-Flores et al., 1999).   
In a review article by Sweet, Doninger, Zee, and Wagner (2004), the authors 
recommended future studies to investigate the relationship between sleep disturbance and 
cognition in SLE in order to better inform clinical practice.  The general pediatric 
literature and heuristic models indicate an association between sleep-disordered breathing 
and executive dysfunction (Archbold, Girodani, Ruzicka, & Chervin, 2004; Beebe, 2005; 
Beebe et al., 2004).  Although research suggests mild cognitive difficulties in children 
and adolescents with SLE (Papero, Bluestein, White, & Lipnick, 1990; Wyckoff, Miller, 
Tucker, & Schaller, 1995), no studies have examined the relationship between sleep-
disordered breathing and executive dysfunction in this population.  Executive dysfunction 
imposes a serious risk to children and adolescents with SLE during their critical years of 
cognitive and educational development.  These pediatric sleep speculative models also 
suggest that risk and resilience factors may contribute to the relationship between sleep-
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disordered breathing and executive dysfunction (Beebe, 2005).  In SLE, different illness-
related risk factors may contribute to this relationship.  
The purpose of this study was to conduct a multi-site project to investigate sleep-
disordered breathing in SLE.  This study attempted to examine a broad developmental 
age range of children and adolescents with SLE between the ages of 8:0 to 18:11 years 
old.  This study was designed to use a control group and a reliable sleep functioning 
measure.  The first aim was to determine if symptoms of sleep-disordered breathing 
occurred more in children and adolescents with SLE compared to a control group.  The 
second aim was to determine if there was an association between symptoms of sleep-
disordered breathing and executive dysfunction in those with SLE.  The third aim was to 
determine if certain risk factors moderated (i.e., disease severity, disease activity) and/or 
mediated (i.e., depression) the relationship between sleep-disordered breathing and 
executive dysfunction in those with SLE.  
The following literature review includes a description of SLE and a review of the 
literature regarding sleep-disordered breathing.  This review will also discuss the 
heuristic models that propose explanations for the association between sleep-disordered 
breathing and executive dysfunction.   
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 Systemic Lupus Erythematosus (SLE) 
2.1.1 Description 
Pierre Cazenave and Henri Schedel provided the first detailed description of SLE 
in 1851 (Wallace & Lyon, 1999).  Today, SLE is described as a disorder of the immune 
system that is systemic, in that it attacks multiple organs (Jump et al., 2005).  These 
systems may include the skin, blood, joints, lungs, heart, kidneys, liver, brain, and the 
nervous system (Lash, 1998).  Seventy percent of SLE cases are systemic and 50% of 
those cases will affect a major organ (Lupus Foundation of America, 2006).  There are 
two other forms of lupus including discoid lupus and drug induced lupus (Lupus 
Foundation of America, 2006).  Discoid lupus is limited to a skin rash.  Drug induced 
lupus is a reversible condition resulting in symptoms similar to SLE.  It can reportedly 
develop from the use of some 38 drugs, but most commonly from the use of 
procainamide, hydralazine, and quinidine.  The current study focuses on SLE. 
The exact prevalence of SLE is difficult to estimate from the epidemiological 
literature (Kardestuncer & Frumkin, 1997; McCarty et al, 1995; Michet, McKenna, 
Elveback, Kaslow, & Kurland, 1985; Siegel & Lee, 1973; Uramoto et al., 1999).  In the 
United States, a study from 1998 estimated that about 40 to 50 people in the United 
States out of every 100,000 have SLE (Lawrence et al., 1998).  A study from 1985, in 
Sweden, indicated that 39 people out of every 100,000 individuals in Sweden have SLE 
(Nived, Sturfelt, & Wollheim, 1985).  Another study from 1994 reported that in the 
United Kingdom the prevalence of SLE was 24.7 out of every 100,000 in the population 
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(Hopkinson, Doherty, & Powell, 1994).  In this same study, SLE occurred in 207.0 out of 
100,000 Afro-Caribbean females, 48.8 out of 100,000 Asian females, and 20.3 out of 
100,000 Caucasian females (Hopkinson et al., 1994).  This study highlights that SLE is 
generally more common in females and ethnic minorities.  In a study by Anstey, Bastian, 
Dunckley, and Currie (1993), the authors concluded there was a prevalence of SLE in 1 
out of every 1,900 Australian aborigines, which is twice that estimated in non-aboriginal 
Australians.  
Currently, no known single gene causes SLE; however, there is an association 
between some genes and the disease.  An association exists between a gene on 
chromosome one and the occurrence of SLE in some families (Tsao et al., 1997).  There 
is also an association between the gene on chromosome six, called the immune response 
gene, and the occurrence of the disease (van der Linden et al., 2001).  Some individuals 
with SLE have an altered Runx-1 binding site (Prokunina et al., 2002).  Approximately 
20% of SLE patients have a close relative, including a parent or sibling with the disease. 
However, only 5% of the children born to individuals with SLE will develop the disease 
(Lupus Foundation of America, 2006), suggesting environmental contributions.  Some 
environmental factors may trigger disease onset and/or exacerbate SLE symptoms.  These 
factors include infections, antibiotics, ultraviolet light, extreme stress, certain drugs, and 
hormones (Lupus Foundation of America, 2006). 
The bodys immune system normally makes proteins called antibodies to protect 
it against exogenous antigens such as viruses and bacteria.  In an autoimmune disorder 
such as SLE, the immune system loses its ability to tell the difference between exogenous 
antigens and its own cells and tissues.  In response, the immune system makes antibodies 
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directed against the self, called autoantibodies.  The autoantibodies react with the bodys 
own cells and tissues to form immune complexes.  These immune complexes build up in 
the tissue and cause inflammation, injury to the tissue, and pain. 
SLE is different from other autoimmune disorders because it affects many tissues 
and organs.  In contrast, for example, in multiple sclerosis, the autoimmune reaction is 
directed against the brain and spinal cord.  The autoimmune reaction in rheumatoid 
arthritis attacks bone joints.  In Graves disease, anti-thyroid antibodies stimulate an 
overproduction of hormones.  Hashimotos thyroiditis, also affecting the thyroid by an 
autoimmune reaction, causes inflammation and later dysfunction of the thyroid.  The 
autoimmune reaction in Crohns disease is directed against the gut and intestinal tract.  
Finally, in Type 1 diabetes mellitus, the autoimmune reaction attacks the islet cells of the 
pancreas. 
 
2.1.2 Clinical manifestations 
The course of SLE involves intense flares and periods of remission.  The major 
reported symptoms include the following: achy joints, fever, swollen joints, extreme 
fatigue, skin rashes, anemia, kidney involvement, chest pain, butterfly-shaped rash across 
cheeks and nose, sun sensitivity, hair loss, Raynauds phenomenon (i.e., a condition 
affecting blood flow to the extremities when exposed to temperature changes or 
vibrations), seizures, and mouth or nose ulcers (Kotzin, 1996).  For females, an increase 
in disease symptoms sometimes occurs before menstruation and/or during pregnancy 
(Kotzin, 1996). 
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Some individuals with SLE have central nervous system involvement, 
characterized by neuropsychiatric symptoms (Arkachaisri & Lehman, 1999; Klein-
Gitelman, Reiff, & Silverman, 2002).  These symptoms usually manifest within the first 
year of diagnosis of SLE.  According to the American College of Rheumatology 
nomenclature and case definitions, there are 19 neuropsychiatric symptoms associated 
with SLE (American College of Rheumatology Ad Hoc Committee on Neuropsychiatric 
Lupus Nomenclature, 1999).  Symptoms associated with central nervous system 
involvement include aseptic meningitis, cerebrovascular disease, demyelinating 
syndrome, headaches, movement disorder, myelopathy, seizure disorders, acute 
confusional state, anxiety disorder, cognitive dysfunction, mood disorder, and psychosis.  
Symptoms associated with peripheral nervous system involvement include acute 
inflammatory demyelinating polyradiculoneuropathy, autonomic disorder, 
single/multiplex mononeuropathy, myasthenia gravis, cranial neuropathy, plexopathy, 
and polyneuropathy.  There are inconsistent reports of the prevalence of neuropsychiatric 
symptoms in SLE in children, with statistics ranging from 48% to 95% (Sibbitt et al., 
2002; Steinlin et al., 1995).  Less formal chart review studies indicate that between 36% 
and 48% of children from SLE samples demonstrated depressive symptoms (Parikh, 
Swalman, & Kim, 1995; Steinlin et al., 1995).  
Neuropsychiatric symptoms in SLE are thought to be caused by antibodies 
attacking blood vessels in the body, causing these blood vessels to be ineffective in 
delivering nutrients and oxygen to the central nervous system (Lupus Foundation of 
America, 2006).  Nerve tissue damage occurs when nerves lack these vital elements.  
Imaging studies in adults with SLE with central nervous system involvement have 
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identified focal deficits, diffuse bitemporal-parietal patterns, structural changes including 
atrophy, and volumetric changes (Chinn et al., 1997; Rogers et al., 1992).  
 
2.1.3 Diagnosis 
Diagnosis of SLE occurs between the age of 15 and 45 in approximately 80% of 
individuals, with diagnosis in childhood occurring in approximately 15% to 20% of cases 
(McGhee et al., 2004; Stichweh, Arce, & Pascual, 2004).  No single laboratory test can 
confirm the presence of SLE (Lupus Foundation of America, 2006); however, several 
laboratory tests help to identify the disease.  A diagnosis of SLE occurs after a review of 
the patients medical history, a physical examination, and the results of laboratory tests 
related to immune status.  The lupus erythematosus (LE) cell test was the first laboratory 
test developed to help diagnose SLE (Dubois, 1953).  The administration of this test is 
rarely used today because it is not specific to SLE and can be positive in other disorders 
(i.e., such as rheumatoid arthritis, Sjogrens syndrome, scleroderma, patients with liver 
disease, and in people taking certain drugs). 
Currently, three categories of diagnostic tests help to diagnose SLE (National 
Institute of Arthritis and Musculoskeletal and Skin Diseases, 2001).  The three types of 
tests assess the following: blood cell abnormalities (i.e., tests for anemia, leucopenia, and 
thrombocytopenia), autoimmunity (i.e., antinuclear antibody [ANA], anti-Sm, anti-
nDNA, anti-Ro [SSA], anti-La [SSB], complement, erythrocyte sedimentation rate 
(ESR), C-reactive protein [CRP], antiphospholipid antibodies [APLs], syphilis serology, 
anticardiolipin antibody [ACA], and lupus anticoagulant) and kidney function (i.e., 
glumerular filtration rate, urinalysis, serum creatinine concentration, and kidney biopsy).  
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The American College of Rheumatology devised 11 criteria, of which 4 should be 
present, to help diagnose SLE (Hochberg, 1997; Tan et al., 1982).  The SLE criteria 
include symptoms of malar rash, discoid rash, photosensitivity, oral ulcers, arthritis, 
serositis, renal disorder, neurological disorder, hematologic disorder, immunologic 
disorder, and abnormal ANA titer (Tan et al., 1982).  Physicians apply these diagnostic 
criteria to both adults and children. 
 
2.1.4 Treatment 
There is no cure for SLE; however, medication and lifestyle choices help to 
control symptoms and prevent flares.  For photosensitive individuals with SLE, 
avoidance of excessive sun exposure and use of regular sunscreen helps prevent rashes 
(Lupus Foundation of America, 2006).  Regular exercise assists in preventing muscle 
weakness and fatigue.  Immunizations protect against some infections.  Emotional rest, 
social support, and counseling help to relieve stress (National Institute of Arthritis and 
Musculoskeletal and Skin Diseases, 2001).  A healthy well-balanced diet and physical 
rest also help to alleviate symptoms.  Smoking, excessive consumption of alcohol, too 
much or too little of a prescribed medication, or postponing regular medical checkups can 
result in an increase in flare-ups and disease activity.  Medication for symptom 
management depends on symptoms and organ involvement.  Medications commonly 
used include non-steroidal anti-inflammatory drugs, acetaminophen, corticosteroids, 
antimalarials, immunomodulating drugs, and anticoagulants. 
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2.1.5 Mortality and morbidity 
Mortality rates in SLE are associated with socioeconomic status, individual access 
to health care, educational background, ethnicity due to low socioeconomic status and 
reduced access to healthcare, endemic infection rates, disease activity, renal involvement, 
and central nervous system symptoms (Cook, Gladman, Pericak, & Urowitz, 2000).  
Cardiac disease is a significant cause of morbidity and mortality in children and adults 
with SLE.  Pulmonary function is abnormal in a majority of children with SLE.  When it 
occurs, mortality is 90% even with treatment by corticosteroids and other 
immunosuppressive agents (Ciftci et al., 2004; Paran, Fireman & Elkayam, 2004).  In the 
past, Lupus nephritis led to increased morbidity and mortality in SLE; however, because 
of successful treatment with cyclophosphamide or azathioprine, prognosis has increased 
to a survival rate of 94% (Hagelberg et al., 2002).  In children, neuropsychiatric symptom 
involvement is associated with significantly higher rates of morbidity and mortality 
(Vyas, Hidalgo, Baqi, Von Gizyki, & Singh, 2002).  
The survival rate of individuals with SLE has drastically improved because of 
earlier diagnosis and better approaches to therapy.  These advancements in treatment help 
to control acute organ attack and inflammatory response.  In 1955, the 5-year survival 
rate for those with SLE was less than 50% (Merrel & Shulman, 1955).  In the 1960s, 
physicians began prescribing glucocorticosteroids, which prolonged the lives of these 
individuals.  In 1995, the 5-year survival rate rose to 93% and the 20-year survival rate 
was 68% (Abu-Shakra, Urowitz, Gladman, & Gough, 1995).  A report from 2004 
indicated that the 5-year survival rate for pediatric onset SLE was 100% and the 10-year 
survival rate was 86% (Miettunen et al., 2004).  
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2.1.6 Cognitive functioning 
A literature review uncovered only two studies examining cognitive functioning 
in children with SLE.  A study by Papero and colleagues (1990) compared 21 children 
with SLE with a mean age of 15 years old who had no overt central nervous system 
involvement to 11 children with juvenile rheumatoid arthritis.  The participants 
constituted a middle class sample, with 86% being female and 71% being African 
American.  The participants were administered a battery of neuropsychological tests (i.e., 
Wechsler Intelligence Scale for Children-Revised, Wisconsin Card Sorting Test, 
Category Test, Seashore Rhythm, Speech Sounds Perception, Finger Tapping, Hand 
Dynamometer, Reitan-Klöve Sensory Perceptual Exam, and Trail Making tests).  The 
SLE group had average intellectual abilities (Full Scale IQ, M = 95.8, SD = 20.2).  They 
displayed a statistically but not clinically significant lower score on a complex problem 
solving task compared to those with arthritis, with the score in the low end of the average 
range (M = 90, SD = 14.4).  A longer duration of SLE was associated with more 
cognitive difficulties.  In this study, 43% of the children with SLE had 
neuropsychological difficulties compared to only 18% of those with juvenile rheumatoid 
arthritis.  Cognitive difficulties were defined by a score two or more standard deviations 
below the individuals FSIQ. 
Another study compared 8 children with SLE ranging in age from 9 to 17 years 
old to neuropsychological test normative data, but not to a healthy control group 
(Wyckoff et al., 1995).  Females comprised 75% of the participants.  Ethnicity of the 
sample was not reported.  The participants were administered a battery of cognitive tests 
(i.e., Wechsler Intelligence Scale for Children-Revised, Wechsler Adult Intelligence 
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Scale-Revised, Wide Range Achievement Test, Gates Comprehension, Trails A and B, 
Finger Oscillation Test, Wechsler Memory Scale, Stanford Binet Intelligence Scale-
Fourth Edition Memory Scale, Achenbach Child Behavior Checklist, and Achenbach 
Youth Self Report).  Performances were below the normal range on the Wechsler 
Memory Scale (M = 70.0, SD = 8.4) and Stanford Binet Memory scale (M = 74.4, SD = 
25.8), and were low average on the measures of intelligence (Full Scale IQ, M = 85.2, SD 
13.9).  The authors described slow sequential processing speed on Trails B; however, a 
standardized score was unavailable for verification.  Despite the small sample size and 
possible low power in these studies, results suggest the presence of mild cognitive 
difficulties in small samples of children and adolescents with SLE.  
 
2.1.7 Summary of SLE 
 In summary, SLE is a chronic inflammatory multi-system autoimmune disease.  
In the U.S., SLE occurs in 40 to 50 people out of every 100,000, with 15% to 20% of all 
SLE cases being children (McGhee et al., 2004; Stichweh et al., 2004).  Although 
children with SLE have the same disease symptoms as adults, SLE can be even more 
devastating for children.  Children have higher rates of organ involvement and a more 
aggressive clinical course compared to adults (Rood et al., 1999).  Since 80% of 
individuals with SLE develop the disease between the age of 15 and 45 (Lupus 
Foundation of America, 2006), there are a limited number of children with SLE.  
Therefore, few research studies have investigated functioning in these children.  The two 
studies that investigated cognitive functioning in children with SLE suggest mild 
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cognitive difficulties.  The current study aims to provide more detailed information into 
the area of executive function in children and adolescents with SLE. 
 
2.2 Sleep-Disordered Breathing  
2.2.1 Description 
 William Hill (1889) provided the first description of sleep-disordered breathing, 
explaining that symptoms caused backwardness and stupidity in children.  He 
described this impaired daytime functioning as secondary to impairment in cerebral 
functions.  Recent research suggests that children with sleep-disordered breathing have 
executive functioning, academic, and behavioral difficulties (Archbold et al., 2004; 
Beebe et al., 2004; Lewin, Rosen, England, & Dahl, 2002).  Together these deficits are 
termed neurobehavioral dysfunction because of their presumed association with 
impaired brain functioning.  
Sleep-disordered breathing is the overarching term referring to a spectrum of 
severities of upper airway resistance problems.  The spectrum ranges in severity in the 
following order from mild to severe: primary snoring, upper airway resistance syndrome, 
partial obstructive hypoventilation hypopneas, and obstructive sleep apnea (Anstead, 
2000).  Sleep-disordered breathing can be caused by adenotonsillar hypertrophy, over-
relaxed muscles in the throat, fat deposits in the throat, and nasal deformities (Ali, Pitson, 
& Stradling, 1996; Ward & Marcus, 1996). 
At the mild end of the spectrum, individuals have increased difficulty in breathing 
because of airway resistance and have minimal arousals, but no apnea (complete pause in 
breathing), hypopnea (partial pause in breathing), or hypoxemia (insufficient oxygenation 
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of the blood; Anstead, 2000).  At the more severe end of the spectrum, the common 
nighttime symptoms include loud snoring, breathing pauses, struggling to breathe, 
restless sleep, sweating, and odd sleeping positions.  Furthermore, the upper airway 
collapses causing hypopnea or apnea, resulting in recurrent arousals from sleep and 
leading to sleep deprivation and waking hypersomnolence.  Individuals with the more 
severe forms experience decreased blood oxygenation saturation levels, producing 
hypoxemia in surrounding tissue and in the brain (Dahl, 1996; Marcus & Loughlin, 
1996).  These repeated hypoxic episodes return to normal blood oxygenation saturation 
levels throughout the night.  Symptoms including respiratory disturbance, increased rates 
of arousal, and repeated fragmentation of sleep occurring during the night are related to a 
decrease in optimal daytime functioning (Greenberg, Watson, & Deptula, 1987; 
Randazzo, Muehlbach, Schweitzer, & Walsh, 1998).   
Research indicates that sleep-disordered breathing is related to underlying 
inflammation (Alberti et al., 2003; Tauman et al., 2004).  Immunoregulatory proteins 
(i.e., also called cytokines) mediate and regulate immunity, inflammation, and 
hematopoiesis and there are many different types of these proteins involved in this 
process (i.e., interleukins, interferon gamma, transforming growth factor, tumor necrosis 
factor, and c-reactive protein).  In this research area, a literature review only found one 
study investigating immunoregulatory proteins in children.  This study investigated sleep-
disordered breathing in 81 children ranging in age from 3 to 18 years and indicated an 
increase in c-reactive protein (Tauman et al., 2004) in this group.  Other literature has 
investigated immunoregulatory proteins in adults with sleep-disordered breathing.  For 
example, a study by Alberti and colleagues (2003) examined immunoregulatory proteins 
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in a subset of 18 adults with obstructive sleep apnea and 20 controls.  Results from this 
study indicated higher levels of tumor necrosis factor, an increase in interleukin 6, and a 
significant decrease in the levels of interleukin 10 among those with obstructive sleep 
apnea compared to the control group.  In a study by Shamsuzzaman and colleagues 
(2002), the authors compared 22 adults with obstructive sleep apnea to 20 controls 
matched for age and body mass index.  In this study, c-reactive protein levels were higher 
in those with obstructive sleep apnea than in controls.   
Research indicates that demographic factors such as socioeconomic status, 
ethnicity via socioeconomic status, and body mass index are related to sleep-disordered 
breathing.  A study by Chervin and colleagues (2003) investigated sleep-disordered 
breathing in 145 children from 8 to 11 years old, of which 40% were male.  In this 
sample, 58% were non-African American and 42% were African American.  Parents 
completed the Pediatric Sleep Questionnaire.  The results indicated there was an 
association between the existence of sleep-disordered breathing and lower socioeconomic 
status, when controlling for ethnicity (Chervin et al., 2003).  Another study by Urschitz 
and colleagues (2004), evaluated 1,144 children in third grade for primary snoring.  In 
this group, there was an association between snoring and lower socioeconomic status.  A 
study by Beebe and colleagues (2006) investigated the relationship between obesity and 
sleep-disordered breathing in 60 overweight adolescents ranging in age from 10 to 16.9 
years old.  The overweight group was comprised of 67% females and 97% African 
Americans.  These participants were compared to 22 healthy children.  Procedures 
included a polysomnography study, actigraphy, and a parent-report questionnaire called 
the Childrens Sleep Habits Questionnaire.  The overweight children exhibited more 
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sleep-disordered breathing than the healthy controls.  Other studies evaluating overweight 
children indicate 24% (Mallory, Fiser, & Jackson, 1989) to 36% (Marcus & Loughlin, 
1996) of the sample groups had sleep-disordered breathing. 
 
2.2.2 Sleep-disordered breathing in children and adolescents 
The most recent national studies of sleep problems were conducted with children 
and adolescents in 2004 and 2006 by the National Sleep Foundation (2004, 2006).  Two 
studies were conducted examining sleep functioning in a sample of 646 school age 
children ranging in age from 6 to 10 years old and a group of 1,602 adolescents ranging 
in age from 11 to 17 years old.  Results from these parent-report surveys indicated that 
snoring occurred in 18% of children and adolescents.  A study by Johnson and Roth 
(2006) examined sleep-disordered breathing by parent and adolescent report in 1,014 
adolescents between the age of 13 and 16.  Results of this study suggested that 
approximately 20% snored and 3% to 6% of adolescents had obstructive sleep apnea 
symptoms.  Sanchez-Armengol and colleagues (2001) examined sleep-disordered 
breathing in a sample of 101 adolescents from 12 to 16 years old.  In this study, results 
from a cardiorespiratory polygraphy study indicated 29% of these individuals snored and 
sleep apnea occurred in 3% of the adolescents. 
 Sleep-disordered breathing is common in children with chronic medical illness, 
including children with diabetes and sickle cell disease (SCD).  In SCD, research 
indicates that obstructive sleep apnea and nighttime oxygen desaturation occurs in up to 
40% of these children and adolescents (Castele, Stohl, Chester, Brittenham, & Harris, 
1988; Franco et al., 1996).  In this population, there is an association between low oxygen 
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saturation and high rates of painful crises.  One study investigated sleep-disordered 
breathing in a sample of 35 children with SCD ranging in age from 4 to18 years old, with 
74% of the sample being male (Kothare, Grant, Coleman, & Dampier, 2005).  Ethnicity 
information was unavailable, although a majority of individuals with SCD are African 
American.  Results indicated that these children had sleep disruption problems, as 
indicated by a higher prevalence of excessive daytime sleepiness and sleep-disordered 
breathing.  Research also suggests children with diabetes have co-occurring obstructive 
sleep apnea (Villa et al., 2000).  A study by Villa and colleagues (2000) investigated 
obstructive sleep apnea in 25 children with insulin-dependent diabetes mellitus.  These 
children ranged in age from 5 to 11 years old, were mostly male (76%), and were of 
average weight.  Information regarding ethnicity was unavailable.  The children with 
diabetes had a higher prevalence of obstructive sleep apnea than 20 age-matched 
controls.  Specifically, sleep-disordered breathing was associated with duration of 
diabetes and to their glycaemic control.  
 Children with neurodevelopmental disorders are also reported to have a high 
incidence of sleep-disordered breathing.  In a clinic based questionnaire study, 
approximately 20% of the 83 children with spina bifida had moderate to severe sleep-
disordered breathing (Kirk, Morielli, & Brouillette, 1999).  Another research study 
investigated sleep-disordered breathing in 46 children diagnosed with Attention-Deficit 
Hyperactivity Disorder (ADHD) ranging in age from 5 to 9 years of age, of which 79% 
were male (Owens, Maxim, Nobile, McGuinn, & Msall, 2000).  Information on ethnicity 
was unavailable.  This study revealed that children with ADHD had more symptoms of 
sleep-disordered breathing than 46 healthy controls.  A study that examined sleep-
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disordered breathing among 23 children with Down Syndrome reported an increase in 
sleep-disordered breathing in this population, including more nighttime movements and 
arousals than a healthy control group (Levanson, Tarasiuk, & Tal, 1999).  
   
2.2.3 Executive dysfunction and sleep-disordered breathing  
One consequence of sleep-disordered breathing may be problems in executive 
function.  Executive functions are cognitive abilities used to control and regulate ones 
behaviors, and are higher-level abilities that involve attention, problem-solving, working 
memory, mental flexibility, and abstract reasoning.  Beebe and Gozal (2002) offer a 
provisional prefrontal cortex model (see Figure 1) of sleep-disordered breathing 
describing the daytime impairments first described by Hill (1889).  In this causal model, 
sleep disruption, hypoxemia (insufficient oxygenation of the blood), and hypercarbia 
(presence of high levels of carbon dioxide in the blood) alter restorative processes that 
occur during sleep.  These disruptions interrupt the functional homeostasis and neuronal 
viability within the prefrontal cortical areas, leading to dysfunction of the brains 
cognitive executive system.  Subsequently, this disruption results in adverse day time 
effects including difficulties with mental manipulation, poor judgment/planning, 
disorganization, and impulsivity.  Furthermore, a neurobehavioral functioning heuristic 
model of sleep-disordered breathing by Beebe (2005) proposes that certain risk and 
resilience factors may contribute to the relationship between sleep-disordered breathing 
and executive dysfunction in the pediatric population (see Figure 2).  In this model, 
illness-related (i.e., disease duration, disease activity, disease severity), demographic (i.e., 
age, gender, socioeconomic status, cognitive reserve, body mass index), and comorbid 
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(i.e., depression) factors are proposed to potentially moderate the relationship between 
sleep-disordered breathing and executive dysfunction.   
Several research studies have investigated executive functioning in children with 
sleep-disordered breathing.  Beebe and colleagues (2004) investigated cognitive 
performance among the spectrum of severity of sleep-disordered breathing (i.e., primary 
snoring, mild OSA, and moderate-severe OSA) in 32 children ranging in age from 6 to 12 
years old compared to controls.  From the overall sleep-disordered breathing group, 59% 
were males and 37% were reported to be from a minority population.  Procedures 
included a polysomnography study, cognitive testing (i.e., Wechsler Intelligence Scale 
for Children-Third Edition, Wide Range Assessment of Memory and Learning, Stroop 
Test, Gordon Diagnostic System, NEPSY, and Wisconsin Card Sorting Test) and parent-
report measures including the Childrens Sleep Habits Questionnaire, the Behavioral 
Assessment Scale for Children (BASC), and the Behavior Rating Inventory of Executive 
Function (BRIEF).  The authors concluded that some subgroups of these children 
displayed clinically and statistically significant elevated scores on the BRIEF and BASC 
on measures of impulsivity (i.e., primary snoring group), emotional control (i.e., primary 
snoring group, moderate-severe OSA group), working memory (i.e., primary snoring 
group, moderate-severe OSA group), planning (i.e., primary snoring group), and self-
monitoring (i.e., primary snoring group) compared to 17 controls.  In addition, the 
authors concluded that some subgroups displayed only statistically significant elevated 
scores on the BRIEF and BASC on measures of impulsivity (i.e., mild OSA group, 
moderate-severe OSA group), emotional control (i.e., mild OSA group), self-initiation of 
activities (i.e., primary snoring group, mild OSA group, Moderate-Severe OSA group), 
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working memory (i.e., mild OSA group), organization (i.e., primary snoring group, 
moderate-severe OSA group), and self-monitoring (i.e., mild OSA group, moderate-
severe OSA group).  The authors also reported that all groups exhibited mildly decreased 
verbal fluency (low end of average) and visual attention skills (low average).  
Some studies investigated cognitive functioning in individuals with sleep-
disordered breathing of different levels of severity, such as in those with moderate to 
severe obstructive sleep apnea.  One study investigated cognitive functioning in 28 
children ranging in age from 4 to 12 years-old, with 69% of the sample being female 
(Lewin et al., 2002).  Information on ethnicity was unavailable.  These individuals were 
at the severe end of the sleep-disordered breathing spectrum with moderate to severe 
obstructive sleep apnea.  Procedures included a polysomnography study, administration 
of the Differential Abilities Scale, and parent-report questionnaires including the 
Brouillette Apnea Symptom Scale and Achenbach Child Behavior Checklist.  Compared 
to an age-matched comparison group of 10 children, the children with obstructive sleep 
apnea had statistically but not clinically significant more behavioral problems and they 
demonstrated mild difficulty on a task involving visual processing speed and sustained 
attention.  
Some studies have investigated cognitive functioning in individuals with mild 
levels of sleep-disordered breathing.  A study by Archbold and colleagues (2004) 
examined cognitive functioning in 12 children from 8 to 11 years old with only mild 
levels of sleep-disordered breathing.  Procedures included a polysomnography study, 
sleep latency test, and administration of cognitive testing (i.e., Integrated Visual and 
Auditory Continuous Performance Test, Childrens Memory Scale, Childrens Category 
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Test, Wechsler Abbreviated Scale of Intelligence, and Wechsler Individual Achievement 
Test).  These children had significant deficits, scoring in the borderline range, in areas of 
executive functioning including sustained attention, vigilance, and mental flexibility, but 
had no impairment in general intelligence.  In this study, there was an association 
between a higher arousal index from a polysomnography study and low mental flexibility 
on a problem solving task.   
Research that has investigated primary snoring in children indicates a decrease in 
executive functioning abilities in this group as well.  For example, a study by Kennedy 
and colleagues (2004) evaluated 13 Caucasian children ranging in age from 5 to 10 years 
old who snored compared to 13 children who did not snore.  Procedures included a 
polysomnography study and administration of cognitive testing (i.e., Wechsler Preschool 
and Primary Scale of Intelligence-Revised, Wechsler Intelligence Scale for Children-
Third Edition, Wide Range Assessment of Memory and Learning, and Auditory 
Continuous Performance Test).  Although these children had a normal obstructive 
respiratory disturbance index on the polysomnography study, there were some 
polysomnographic variables that were related to cognitive functioning.  For example, 
there was a relationship between the severity of neurocognitive difficulties with the 
number of mild oxygen desaturations, obstructive hypopneas, and respiratory arousals.  
Specifically, the authors reported that those who snored had statistically significant lower 
scores on measures of intelligence and memory, but not clinically significant as these 
scores were in the lower end of the average range.  These authors also indicated that 
those who snored had statistically significant lowered scores on a measure of selective 
and sustained attention.  In another study by Blunden, Lushington, Kennedy, Martin, and 
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Dawson (2000), participants included 16 children who snored from 5 to 10 years old, of 
which 44% were male.  There was no indication of ethnicity.  The control group 
consisted of 16 individuals who did not snore.  Procedures included a polysomnography 
study, administration of cognitive testing (i.e., Wechsler Preschool and Primary Scale of 
Intelligence-Revised, Wechsler Intelligence Scale for Children-Third Edition, Wide 
Range Assessment of Memory and Learning, and Auditory Continuous Performance 
Test), and parent-report questionnaires including the Achenbach Child Behavior 
Checklist and Sleep Disturbance Scale for Children.  According to the authors, the 
children who snored had significantly impaired attention, and although within the normal 
range, lower memory and intelligence scores. 
 
2.2.4 Sleep-disordered breathing and its relationship with executive functioning in SLE  
Sleep-disordered breathing has not been extensively studied in SLE and research 
findings are inconsistent, despite the fact that clinicians and patients refer to sleep 
problems.  A pilot study investigated sleep functioning assessed by the Childrens Sleep 
Habits Questionnaires in 20 adolescents with SLE that ranged in age from 14 to 20 years 
old (Cruz et al., 2007).  This study initially concluded that these adolescents exhibited 
more symptoms of sleep-disordered breathing compared to normative scores and a 
control group.  However, through recent personal communication with the authors (M. 
Grant, Ph.D, M. Cruz, M.D., personal communication, April, 16, 2008), these authors 
indicated the study was withdrawn due to a significant design flaw.  In this study, the 
adolescents were initially compared to a significantly younger control group.  When the 
SLE group was then compared to a comparably aged control group there were no 
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significant differences in sleep problems (i.e., sleep-disordered breathing, daytime 
sleepiness, bedtime resistance, and sleep duration problems).  The results from this study 
suggest that sleep problems may not be a concern for adolescents with SLE. 
Valencia-Flores and colleagues (1999) also conducted a study to investigate sleep 
disorders in individuals with SLE; however, this study was conducted with an adult 
population that consisted of a small sample of 14 women ranging from 20 to 53 years old. 
Ethnicity information was unavailable.  These researchers used polysomnography in their 
study and found abnormalities in respiration and movement (i.e., periodic leg movement) 
during sleep in these SLE patients.  Fourteen percent of their sample had frequent alpha 
wave intrusions in their sleep EEG.  The SLE group was sleepier during the day than the 
normal group and sleepiness in the SLE group was related to sleep fragmentation (more 
arousals and stage transitions).  The magnitude of the difference was relatively small.  
Disease activity was associated with decreases in sleep efficiency and delta sleep, and 
with increases in sleep fragmentation.  Despite being an adult study, this study suggests 
that sleep problems may occur in the SLE population, specifically those who are adults. 
In SLE, illness-related factors (i.e., disease activity, disease severity, depression) 
may be the underlying variables that may make individuals with SLE more at risk for 
sleep-disordered breathing and executive functioning difficulties.  Illness-related factors 
also may be the underlying variables that could contribute to the relationship between 
sleep-disordered breathing and executive dysfunction in SLE.  Specifically, when 
individuals with SLE have an increase in disease activity, immunoregulatory proteins are 
active in the body.  Some of these proteins have a crucial anti-inflammatory role by 
controlling the level of pro-inflammatory proteins (Xing et al., 1998).  Only research 
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studies in the adult SLE population have examined immunoregulatory proteins in detail 
in SLE.  One study by Lacki and colleagues (1997) investigated immunoregulatory 
proteins in 71 adults with SLE, of which 97% were women.  In this study, there was an 
elevation of interleukin 10 and interleukin 6 in those with SLE compared to those with 
rheumatoid arthritis.  Another study by Gabay and colleagues (1997) examined 
immunoregulatory proteins in 52 adults with SLE.  These authors reported that those with 
SLE displayed an increase in interleukin 6 and tumor necrosis factor.  In another study by 
ter Borg, Horst, Limburg, van Rijswijk, and Kallenberg (1990), c-reactive protein levels 
were higher in a group of 71 adults with SLE during disease exacerbations and infections 
than before or after these times.  This research is important because as previously 
mentioned, immunoregulatory proteins are also actively involved in sleep-disordered 
breathing.  Therefore, in SLE, illness-related factors may make some individuals more 
susceptible to sleep-disordered breathing and executive functioning difficulties. 
 
2.2.5 Summary of sleep-disordered breathing  
 In summary, there is limited and conflicting research investigating sleep-
disordered breathing in SLE (Cruz et al., 2007; Valencia-Flores et. al., 1999).  Research 
indicates that immunoregulatory proteins are involved both in the inflammation process 
in SLE and sleep-disordered breathing (Alberti et al., 2003; Gabay et al., 1997; Lacki et 
al., 1997; Tauman et al., 2004), which suggests that those with SLE may be at risk for 
sleep-disordered breathing.  The literature and heuristic models suggest a relationship 
between sleep-disordered breathing and executive dysfunction (Archbold et al., 2004; 
Beebe, 2005; Beebe and Gozal, 2002; Beebe et al., 2004).  In addition, a heuristic model 
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by Beebe (2005) proposes that risk and resilience factors, such as illness-related factors, 
may contribute to the relationship between sleep-disordered breathing and executive 
dysfunction.  The aim of the current study was to provide further detailed information 
into sleep-disordered breathing in children and adolescents with SLE. 
 
2.3 Present Study 
2.3.1 Purpose and rationale   
There is scarce research on sleep-disordered breathing and its relationship with 
executive functioning in children and adolescents with SLE.  The first goal of this study 
was to examine the occurrence of sleep-disordered breathing in a pediatric sample with 
SLE (age range = 8 to 18 years old).  There are inconsistent findings in research 
investigating sleep-disordered breathing in this population (Cruz et al., 2007; Valencia-
Flores et. al., 1999).  However, a formal polysomnography study found abnormalities in 
respiration and movement during sleep in an adult SLE sample (Valencia-Flores et. al., 
1999).  The inflammation in SLE is regulated by immunoregulatory proteins (Gabay et 
al., 1997; Lacki et al., 1997), and immunoregulatory proteins have also been found to 
contribute to sleep-disordered breathing (Alberti et al., 2003; Tauman et al., 2004).  
Therefore, those with SLE with more disease activity or more profound disease severity 
may be at increased risk for developing sleep-disordered breathing.  Hence, further 
investigation of sleep-disordered breathing in a younger sample of individuals with SLE 
was warranted.  The present study was set forth to evaluate a broad age range of children 
and adolescents, recruit for an adequate sample size, use a reliable sleep questionnaire, 
and use a comparison control group.  
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Difficulties with executive functioning have been documented in pediatric 
samples with sleep-disordered breathing (Archbold et al., 2004; Beebe et al., 2004).  
Furthermore, the literature investigating cognitive functioning in children with SLE 
indicates mild cognitive difficulties in this population (Papero et al., 1990; Wyckoff et 
al., 1995).  The second goal of this study was to examine whether symptoms of sleep-
disordered breathing were related to executive functioning difficulties.  To evaluate 
executive functioning, the present study was designed to use a multi-modal approach 
using both questionnaires and paper/pencil measures to assess executive functioning.  
These study measures will be discussed in relation to their usability as screening 
measures.  Heuristic sleep models propose that certain risk and resilience factors may 
contribute to the relationship between sleep-disordered breathing and executive 
dysfunction (Beebe, 2005; Beebe & Gozal, 2002).  Therefore, the third goal of this study 
was to investigate risk factors that may be specific to SLE and may contribute to the 
relationship between sleep-disordered breathing and executive dysfunction.  The findings 
will be discussed in relation to their consistency with the heuristic sleep-disordered 
breathing models (Beebe, 2005; Beebe & Gozal, 2002).     
The results of this study will hopefully provide a route for future research and 
clinical care.  Identifying children and adolescents with SLE who may be at increased 
risk for sleep-disordered breathing and cognitive problems is important during the crucial 
period of cognitive, educational, and emotional development.  Beginning intervention at 
an early stage may provide for better learning and development opportunities.   
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2.3.2 Hypotheses 
There were three major hypotheses for this study.  Hypothesis 1 examined the 
occurrence of sleep-disordered breathing in children and adolescents with SLE.  This 
hypothesis was based on previous research of the involvement of immunoregulatory 
proteins in SLE (Gabay et al., 1997; Lacki et al., 1997) and in individuals with sleep-
disordered breathing (Alberti et al., 2003; Tauman et al., 2004).  Hypothesis 1 stated that 
the study sample of children and adolescents with SLE would have more parent-reported 
sleep-disordered breathing symptoms than a demographically matched control group. 
Hypothesis 2 examined the association between sleep-disordered breathing and 
executive dysfunction in a pediatric sample with SLE.  This hypothesis was based on 
previous pediatric literature and heuristic models that indicate there is a relationship 
between sleep-disordered breathing and executive dysfunction (Archbold et al., 2004; 
Beebe, 2005; Beebe & Gozal, 2002; Beebe et al., 2004), as well as research involving 
children and adolescents with SLE that suggest mild cognitive difficulties (Papero et al., 
1990; Wyckoff et al., 1995).  Hypothesis 2 stated that there would be an association 
between sleep-disordered breathing (i.e., measured by parent-report) and executive 
dysfunction (i.e., measured by parent-report and by a testing battery) in a sample of 
children and adolescents with SLE. 
Hypothesis 3 examined the contribution of risk factors involved in the 
relationship between sleep-disordered breathing and executive dysfunction in a pediatric 
sample with SLE.  This hypothesis was based on pediatric sleep heuristic models that 
speculate that certain risk and resilience factors may contribute to the relationship 
between sleep-disordered breathing and executive dysfunction in the general pediatric 
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sleep-disordered breathing population (Beebe, 2005; Beebe & Gozal, 2002).  Hypothesis 
3 stated that disease activity and disease severity would act as moderators, and depression 
would act as a mediator, in the relationship between sleep-disordered breathing and 
executive dysfunction in a sample of children and adolescents with SLE. 
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CHAPTER 3: METHOD 
 
3.1 Participants 
3.1.1 Inclusion and exclusion criteria 
Eligible participants included families with children and adolescents between the 
ages of 8:0 and 18:11 for both the SLE and control groups.  Exclusion criteria included 
non-English speaking parents for both groups and non-English speaking children and 
adolescents with SLE.  Individuals with SLE were required to meet the criteria for SLE 
of having 4 out of 11 symptoms for a formal diagnosis (Tan et al., 1982). 
 
3.1.2 Recruitment  
Children and adolescents with SLE were recruited from two rheumatology clinics 
located in Philadelphia, Pennsylvania.  The two hospitals included St. Christophers 
Hospital for Children (SCHC) and The Childrens Hospital of Philadelphia (CHOP).  Of 
those recruited, 25 participants agreed to be in the study and completed the IRB consents.  
Four additional families were approached by a physician when a study recruiter was not 
present and agreed to be contacted about the study.  Attempts to reach these four families 
by phone or at subsequent clinic visits were unsuccessful.  Three additional families were 
not interested in hearing about the study because of time constraints at the clinic.  Out of 
the 25 participants who consented to the study, 17 completed the study requirements 
including the questionnaires and cognitive testing.  An additional 5 participants 
completed the questionnaires, resulting in 22 participants eligible for some of the study 
analyses.  Five participants were from SCHC and 17 were from CHOP.  
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In regard to the comparison group, children/adolescents and their parents were 
recruited from the ambulatory care clinic at St. Christophers Hospital for Children 
(SCHC).  Twenty six out of the 57 initially recruited families failed to mail back their 
questionnaires (i.e., study dropouts).  An amendment to the IRB was accepted to recruit 
an additional 26 families and have all the families complete the questionnaires in clinic.  
Over time, 9 of the original study dropout families completed the questionnaires, leaving 
17 who never returned the questionnaires.  This resulted in 72 participants meeting the 
study requirements.  A total of 14 families were not recruited due to family time 
constraints in the clinic or because a parent was unavailable to complete the consent 
forms and questionnaires.  
 
3.1.3 Selection of matched controls  
 To obtain a demographically matched control group, multiple demographic 
analyses were conducted to best match a subset of the 72 non-SLE individuals to the SLE 
sample.  In order to be blind to the data during the selection process, only demographic 
information including age, income/socioeconomic status, gender, and ethnicity was 
viewable for the SLE and control groups.  Individuals were matched in the following 
order of priority: 1) age, 2) income/socioeconomic status, 3) gender, and 4) ethnicity.  
The best matched sample included 24 controls.  The selected control sample had a similar 
age range (SLE Group: 9  18 years old, Control Group: 9  17 years old).  Mean age 
(SLE Group: 15.5 years old, Control Group: 14.2 years old) and gender (SLE Group: 
77% female, Control Group: 63% female) did not statistically differ or show associations 
(i.e., using t-tests and Chi squares) between groups.  Despite making the control sample 
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more similar in income, Hollingshead score, and ethnicity, these demographic factors 
continued to be statistically different between groups.  Most of the 72 non-SLE 
individuals that completed the questionnaires were from a low socioeconomic status 
bracket and were Hispanic, making it difficult to match the samples without significantly 
reducing the control sample size.  The twenty four selected controls were included in the 
data analyses. 
 
3.2 Measures 
The measures in this study were used to ascertain information about demographic, 
sleep functioning, and cognitive functioning.  The following sections provide a detailed 
description of these measures and Table 1 provides a list of the measures used in this 
study. 
 
3.2.1 Demographic measures 
Parents of the children and adolescents in the SLE and control groups completed 
different versions of a 10 item Child Background Questionnaire (see Appendix A1 and 
A2).  The questionnaire given to parents of individuals in the SLE group asked about 
duration of SLE, while the questionnaire given to parents of those in the control group 
asked if their child was diagnosed with SLE.  The other nine questions were identical, 
and asked parents to report their childs current age, gender, weight, height, ethnic 
background, current medications, throat/ear infections, if they had an adenoidectomy/ 
tonsillectomy, and medical diagnoses.  For both groups, a calculation of height and 
weight determined the childs body mass index and percentile (BMI percentile).  
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Statistical analyses used BMI percentile and age for descriptive and preliminary analyses, 
and ethnicity for descriptive analyses. 
Both groups of parents completed the Parent Background Questionnaire which 
contained six questions (see Appendix B).  One question asked whether the parents 
primary language was English.  The questionnaire also collected information on annual 
household income that was coded as follows: 1 = $0,000-$9,999; 2 = $10,000-$19,999;   
3 = $20,000-$29,999; 4 = $30,000-$39,999; 5 = $40,000-$49,999; 6 = $50,000-$59,999; 
7 = $60,000-$69,999; 8 = $70,000-$79,999; 9 = $80,000-$89,999; 10 = $90,000-$99,999; 
11 = $100,000-$109,999; 12 = $110,000-$119,999; 13 = $120,000-$129,999; and          
14 = $130,000+.  Statistical analyses used the scores from 1 to 14 for descriptive and 
preliminary analyses. 
Questions from the Hollingshead Four Factor Index of Social Status 
(Hollingshead, 1975) questionnaire also were included in the Parent Background 
Questionnaire.  The Hollingshead questionnaire asked for each head of households 
parental role, highest level of education (i.e., coded from one to seven), and current 
employment information (i.e., coded from zero to nine).  The socioeconomic status (SES) 
score was obtained by multiplying the education score by three and the employment 
score by five and then adding the scores together.  For two parents in a household, the 
SES scores for both parents were summed and then divided by two.  On the 
Hollingshead, SES is divided into five categories: 1 = unskilled laborers/menial service 
workers (score of 8-19); 2 = machine operators/semi-skilled workers (score of 20-29);     
3 = skilled craftsman clerical and sales workers (score of 30-39); 4 = medium 
business/minor professional (score of 40-54); and 5 = major business/professional (score 
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of 55-66).  The Hollingshead is a widely used and accepted measure for measuring SES 
and has good validity (Deonandan, Campbell, Ostbye, Tummon, & Robertson, 2000).  
This study used scores for SES for descriptive and preliminary analyses. 
 
3.2.2 Illness-related measures 
A trained study investigator completed the Systemic Lupus Erythematosus 
Disease Activity Index (SLEDAI) for those with SLE.  The SLEDAI is a valid and 
reliable measure to assess disease activity (Bombardier, Gladman, Urowitz, Caron, & Chi 
Hsing, 1992; Hawker et al., 1993).  The questionnaire has 24 weighted items resulting in 
a total score that ranges from 0 to 105.  Higher scores represent more disease activity.  
The weight calculation of the measure is as follows: 8 = seizure, psychosis, organic brain 
syndrome, visual disturbance, cranial nerve disorder, lupus headache, cerebral vascular 
accident, vasculitis; 4 = arthritis, myositis, urinary casts hematuria, proteinuria, pyuria; 2 
= rash, alopecia, mucosal ulcers, pleurisy, pericarditis, low complement, high DNA; and 
1 = fever, low platelets, low white blood cell count.  This study also used the 
inflammatory level of sedimentation rate, which is another predictor of disease activity.  
Sedimentation rate was gathered from the participants medical chart during a chart 
review.  A higher sedimentation rate represented more disease activity.  The SLEDAI and 
sedimentation rate were used in descriptive and primary analyses in this study.  
Measures of disease severity including information about central nervous system 
(CNS) involvement and kidney disease were gathered from the medical chart of those 
with SLE.  CNS involvement in SLE is defined as the occurrence of neuropsychiatric 
symptoms as described by the American College of Rheumatology nomenclature and 
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case definitions.  These symptoms were discussed in the literature review section of this 
study (ACR, 1999).  Presence of CNS involvement and/or kidney disease was used in 
descriptive and primary analyses.  
  
3.2.3 Sleep functioning measure 
Parents of individuals in the SLE and control groups completed the Sleep 
Disorders Inventory for Students (SDIS; Luginbuehl, 2006) to determine parent 
perceptions of their childs sleep behaviors.  The SDIS is a 41-item questionnaire, but 
only 30 of these questions are used for the main scales.  The questionnaire has two 
versions: one for children between the ages of 2-10 years old and another for adolescents 
between the ages of 11-18 years old.  Some questions require a yes/no response and other 
questions are on a Likert scale ranging from 0 to 7.  The measure calculates the following 
scales: Sleep Disturbance Index (SDI), Obstructive Sleep Apnea (OSA), Periodic Limb 
Movement (PLM), Delayed Sleep Phase Syndrome (DSPS), Excessive Daytime 
Sleepiness (EDS), and Narcolepsy (NAR).  Scores are reported as t-scores (M = 50,      
SD = 10).  On this measure, t-scores between 60 and 64 indicate at-risk problems.          
T-scores between 65 and 90 indicate clinically significant level of concerns.  Therefore, 
higher scores reflect more sleep problems.  In the current study, t-scores have been 
converted to standard scores for comparison purposes, with higher scores reflecting more 
sleep problems.  Questions to gather information about tonsillectomies and 
adenoidectomies are also included on this questionnaire.  Norming of this measure 
occurred with 595 parents of children and adolescents from 2 to 18 years old.  According 
to normative data, the internal consistency reliability for the total SDI score for the child 
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version is .91 and for the adolescent version is .92.  For the OSA scale, the internal 
consistency reliability for the child questionnaire is .90 and for the adolescent version is 
.88.  The construction of the ethnic representation of the Sleep Disorders Inventory for 
Students was similar to the 2000 U.S. Census report.  For the current study, all sleep 
scales were incorporated into descriptive analyses.  Preliminary, primary, and exploratory 
data analyses used the OSA scale.  Descriptive and exploratory analyses used the other 
sleep scales.  Data on tonsillectomies and adenoidectomies were used for descriptive and 
preliminary analyses.   
The current study analyzed the reliability of this questionnaire with both the SLE 
and control groups by use of Cronbach alpha reliability analyses (Cronbach, 1951) and 
descriptions of acceptability based on DeVellis (1991).  For the SLE group, on the 
adolescent version, the OSA scale had respectable reliability (α = .71).  For the control 
group, on the adolescent version, the OSA scale had undesirable reliability (α = .65).  For 
both the SLE and control groups, only one child version of the questionnaire was filled 
out, so reliability analyses were not conducted.  The reliability data for the other sleep 
scales can be found in Table 2.     
  
3.2.4 Cognitive functioning measures 
 The investigator administered the cognitive measures only to the children and 
adolescents in the SLE group.  The Wechsler Abbreviated Scale of Intelligence (WASI; 
Wechsler, 1999) was used to provide an estimate of general intellectual ability.  The test 
is appropriate for individuals ranging in age from 6 to 89 years old.  A two subtest 
version to calculate an estimated full scale IQ (FSIQ) was administered, which consisted 
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of the Vocabulary and Matrix Reasoning tests.  The Vocabulary section provides a 
measure of expressive word knowledge and the Matrix Reasoning test provides a 
measure of nonverbal fluid abilities.  This measure calculates the FSIQ as a standard 
score (M = 100, SD = 15; average range = 90 - 110), with lower scores indicating more 
problems.  Standard scores were used in the current study.  The reliability of the FSIQ for 
the normed WASI two subtest version is .96.  The FSIQ was used in descriptive analyses. 
The Behavior Rating Inventory of Executive Function (BRIEF; Gioia, Isquith, 
Guy, & Kenworthy, 2000) is an 86-item parent-report questionnaire for children age 5 to 
18 years old.  The BRIEF provided a subjective but more ecologically based report of the 
childs or adolescents daytime executive function behaviors at home.  The measure has 
eight non-overlapping clinical scales including the following: inhibit, shift, emotional 
control, initiate, working memory, plan/organize, organization of materials, and 
monitoring.  It also contains the Global Executive Composite (GEC) score that combines 
the sum of all eight scales and two indexes that include the Behavioral Regulation Index 
(BRI; 3 scales) and Metacognition Index (MCI; 5 scales).  Scores are reported as t-scores 
(M = 50, SD = 10).  On this measure, t-scores between 65 and 90 indicate clinically 
significant level of concerns.  Therefore, higher scores reflect more sleep problems.  In 
the current study, t-scores have been converted to standard scores for comparison 
purposes, with higher scores reflecting more sleep problems.  Norming for the measure 
occurred with 1,419 parents.  The BRIEF normative data reflect the 1999 U.S. Census 
estimates for socioeconomic status and ethnicity.  The questionnaire has high internal 
consistency of .80 to .98, test reliability of .82, and good convergent validity with other 
measures.  This study used the Global Executive Composite (GEC) score for the 
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descriptive, primary, and exploratory analyses.  The Behavioral Regulation Index (BRI) 
and Metacognition Index (MCI) were used for descriptive and exploratory analyses.  In 
the current studys sample of individuals with SLE, the GEC, BRI, and MCI scores were 
all in the excellent reliability range (α = .98, .93, .97, respectively). 
The investigator administered the Trail Making test from the Delis-Kaplan 
Executive Function System (DKEFS; Delis, Kaplan, & Kramer, 2001).  The Trail 
Making test is a visual motor test that consists of the following five tasks: 1) Visual 
Scanning (VS) requires the individual to find all the number threes on a page, 2) Number 
Sequencing (NS) requires the individual to trace numbers in increasing order, 3) Letter 
Sequencing (LS) requires the individual to trace letters in alphabetical order, 4) Letter-
Number Sequencing (LNS) requires the individual to alternate between tracing numbers 
and letters in order, and 5) Motor Speed (MS) requires the individual to quickly trace a 
dotted line.  An error score is also obtainable called the Letter-Number Sequencing Error 
(LNSE) score.  These scores are reported as scaled scores (M = 10, SD = 3; average range 
= 8 - 12), with lower scores indicating poorer performance.  In the current study, scores 
were converted to standard scores for comparison purposes.  Descriptive, primary, and 
exploratory analyses used the Letter-Number Sequencing score and the Letter-Number 
Sequencing Error score.  Descriptive and exploratory analyses examined the other Trail 
Making scores.   
The investigator administered the Verbal Fluency test from the Delis-Kaplan 
Executive Function System (DKEFS; Delis et al., 2001).  The Verbal Fluency test is 
designed to measure verbal fluency, verbal set shifting, and verbal processing speed and 
is composed of the following three tasks: 1) Letter Fluency (LF) requires the individual to 
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quickly produce words beginning with a specified letter, 2) Category Fluency (CF) 
requires the individual to quickly produce words from a specified category, and 3) 
Category Switching requires the individual to quickly switch back and forth between 
producing words from two categories.  This Category Switching task has two scores, 
Category Switching Number Correct (CS#C) and Category Switching Accuracy (CSA).  
Error scores are also obtainable including the Verbal Fluency Set-Loss Errors (VFSLE) 
score and Verbal Fluency Repetition Errors (VFRE) score.  These scores are reported as 
scaled scores (M = 10, SD = 3; average range = 8 - 12), with lower scores indicating 
poorer performance.  In the current study, scores were converted to standard scores for 
comparison purposes.  This study used the Category Switching Number Correct, Verbal 
Fluency Set-Loss Errors, and Verbal Fluency Repetition Errors scores for descriptive, 
primary, and exploratory analyses.  Descriptive and exploratory analyses used the scores 
for the other scales.   
 The investigator administered the Digit Span (DS) task from the Wechsler 
Intelligence Scale for Children Fourth Edition (WISC-IV; Wechsler, 2003) and the 
Wechsler Adult Intelligence Scale Third Edition (WAIS-III; Wechsler, 1997).  This 
measure provided an objective measure of immediate attention and working memory 
abilities.  The individuals were asked to repeat increasingly lengthy digit strings verbatim 
or in reverse order.  The subscale score is reported as a scaled score (M = 10, SD = 3; 
average range = 8 - 12), with lower scores indicating poorer performance.  In the current 
study, this score was converted to a standard score for comparison purposes.  For the 
WISC-IV, the reliability of the total digit span is .87.  The descriptive, primary, and 
exploratory analyses used the digit span score.  
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3.2.5 Psychiatric functioning measure 
Parents of children and adolescents with SLE completed the Depression and 
Anxiety in Youth Scale (DAYS; Newcomer, Barenbaum, & Bryant, 1994).  This 
questionnaire is a 28-item parent-report questionnaire with scales for Depression, 
Anxiety, and Social Maladjustment for individuals from 6 to 19 years old.  The parent 
responds to true-false questions that ask them to identify the presence or absence of a 
symptom.  This parent-report was normed on 1,286 children from 6 to 19 years old and 
the internal consistency reliability for the Depression scale was .80.  The DAYS 
normative data reflect the 1985 U.S. Census estimates for ethnicity.  This study used the 
Depression scale for descriptive, primary, and exploratory analyses.  In this studys 
sample, the Depression scale had very good reliability (α = .85).  
   
3.4 Order of Administration 
The investigators administered the cognitive testing to the SLE sample in two 
orders (see Table 3).  Order A was: 1) WASI Vocabulary, 2) WASI Matrix Reasoning, 3) 
WISC-IV/WAIS-III Digit Span, 4) DKEFS Trail Making, and 5) DKEFS Verbal 
Fluency.  Order B was: 1) WASI Vocabulary, 2) WASI Matrix Reasoning, 3) DKEFS 
Verbal Fluency, 4) DKEFS Trail Making, and 5) WISC-IV/WAIS-III Digit Span.  Since 
parents completed the questionnaires either in the clinic or at home, and sometimes were 
not in front of the investigator, these questionnaires were completed in no specific order.  
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3.5 Procedure 
Clinics from St. Christophers Hospital for Children (SCHC) and the Childrens 
Hospital of Philadelphia (CHOP) agreed to participate in this study.  Following 
Institutional Review Board (IRB) approval at both hospitals, a clinic staff member from 
the rheumatology or ambulatory care clinic informed parents about the study during their 
clinic visit and a flyer was available describing the study.  In both the rheumatology and 
ambulatory care clinics, a study investigator reviewed the consent form and provided a 
copy of the consent form to families who agreed to participate in the study.  Parents 
signed the consent form, children age 8:0 to 17:11 completed an assent form, and 18 year 
olds completed their own consent form.  The investigator answered any of the familys 
questions about the study.  In addition, the parents were asked to sign a release if they 
wanted the following: 1) to be contacted for scheduling for cognitive testing (for the SLE 
group only) and to remind them to return the questionnaire, 2) if they wanted their childs 
results to be shared with the clinic team, and 3) if they wished to receive a summary by 
mail of the overall study results.  Families from both groups received sleep education 
handouts.  Funding was available from the Childrens Hospital of Philadelphia (CHOP) 
for those individuals recruited from CHOPs rheumatology clinic.  These participants 
received $10 for completion of the study. 
Parents completed the questionnaires during their childs or adolescents clinic 
visit, at home if parents were unable to complete the questionnaires during their clinic 
visit, or during a home visit (for the SLE group only).  Questionnaires for the SLE group 
took approximately 20-35 minutes to complete and questionnaires for the control group 
took approximately 15 minutes to complete.  At the beginning of the study, individuals 
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from the ambulatory care clinic were provided with self-addressed stamped envelopes in 
which to return the questionnaires.  However, many people did not return these 
questionnaires.  These participants were called to mail back their questionnaires, and/or 
complete the questionnaire over the phone.  Because many questionnaires were never 
received, an IRB amendment was approved to recruit more participants from the 
ambulatory care clinic and new recruits were asked to complete the questionnaires in the 
clinic.  When needed, the investigator provided help to parents who had difficulty reading 
the forms.  Due to the difficulty of testing individuals in clinic because of patient no 
shows or time constraints, and an extremely slow data completion rate, an IRB 
amendment was made to conduct home visits.  Testing took 60-75 minutes to administer 
to participants.  Recruitment was ongoing as testing procedures were conducted with 
other participants.  Chart reviews were conducted to gather additional medical 
information.  An investigator was trained by a rheumatology medical resident and nurse 
on how to complete the Systemic Lupus Erythematosus Disease Activity Index 
(SLEDAI) and where to look for disease severity and activity information in the 
individuals medical chart.  
 
3.6 Approach to Data Analyses 
Data analyses were completed using the Statistical Package for Social Science 
(SPSS) version 16.0.  Power was calculated by G-Power TM version 3.0.10 (Faul, 
Erdfelder, Lang, & Buchner, 2007) and by Cohens power tables (1988).  All scores from 
the cognitive testing measures and questionnaires were changed to standard scores for 
comparison purposes.  
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Initial analyses were conducted to prepare for an appropriate sample size and 
comparison group, and to understand the meaning of the data.  Some of the pediatric 
sleep-disordered breathing and SLE literature indicates moderate to large effect sizes 
with small sample sizes (Beebe et al., 2004; Beebe et al., 2006; OBrien et al., 2004; 
Owens, Maxim, et al., 2000; Papero et al., 1990; Wyckoff et al., 1995).  Therefore, power 
was calculated with a medium effect size and a probability level of .05 as the measure of 
significance.  Power for Hypothesis 1 was detected to be .36 and for Hypothesis 2 was 
detected to be .28.  From the non-SLE recruited sample, a group of individuals were 
selected that made for the best demographically matched control group to compare to the 
SLE group.  Since a review of the literature did not indicate that the questionnaires used 
in this study were used on a pediatric population with SLE, reliability analyses for both 
the SLE and control samples were conducted by use of Cronbach alpha statistical 
analyses (Cronbach, 1951; see Methods section and Table 2).  Descriptive statistics for 
different variables described both the SLE and control groups.  Data were examined for 
equality of groups, sample representativeness, reliability of the testing procedures, and 
normal distribution. 
Preliminary analyses for Hypothesis 1 used correlation analyses.  These analyses 
investigated possible covariates of variables known for being related to sleep-disordered 
breathing, including body mass index percentile, age, socioeconomic status (income, 
Hollingshead), tonsillectomies, and adenoidectomies.   
To test Hypothesis 1, an independent samples t-test examined the difference in the 
average score for the obstructive sleep apnea (OSA) scale between the SLE sample and 
control sample.  If necessary, an ANCOVA would be used to covary for possible 
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covariates found to be associated with the OSA scale from preliminary analyses.  This 
analysis used a p-value of .05, and to be conservative, a two-tailed test.   
To test Hypothesis 2, correlation analyses examined the association between the 
obstructive sleep apnea (OSA) scale and the primary executive functioning variables (i.e., 
Global Executive Composite, Category Switching Number Correct, Verbal Fluency Set-
Loss Errors, Verbal Fluency Repetition Errors, Letter-Number Sequencing, Letter-
Number Sequencing Errors, and Digit Span) in the SLE sample.  This analysis used a p-
value of .05 and a two-tailed test.   
To test Hypothesis 3, multiple regression analyses were planned to be used for 
only those executive functioning measures found to be associated with the obstructive 
sleep apnea (OSA) scale from Hypothesis 2.  Hypothesis 3 examined which variables 
moderate (i.e., Systemic Lupus Erythematosus Disease Activity Index, sedimentation 
rate, central nervous system involvement, kidney disease) and mediate (i.e., Depression 
scale) the relationship between the OSA scale and the executive functioning measures in 
those with SLE.  For moderation, the OSA scale would be regressed on the two main 
effects and the interaction term.  To examine mediation, the predictor variable must be 
related to both the outcome variable and mediator variable.  Then the mediator must be 
related to the outcome variable, when the predictor and mediator are entered into a 
multiple regression analysis.  In this same multiple regression analysis, the relationship 
between the predictor and the outcome variable must no longer be significant or must 
decrease in significance. 
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CHAPTER 4: RESULTS 
 
4.1 Summary of data 
4.1.1 Characteristics and equality of groups 
 Table 4 lists the demographic characteristics for the SLE group.  Not all data were 
available for all participants; therefore, averages were calculated for the available data.  
The average age of the 22 participants was 15.5 years old (SD = 2.70, range = 9 - 18).  
Seventeen (77%) were female and five (23%) were male.  Ten (45%) were African 
American, one (4.5%) was Asian, seven (32%) were Caucasian, three (14%) were 
Hispanic, and one (4.5%) was identified as other indicating a different ethnicity.  Out of 
19 participants, results from the Hollingshead Four Factor Index of Social Status 
indicated an average social class rating of 4 out of 5 (range = 2 - 5), which is the second 
highest level.  Out of 17 participants, the average and median annual household income 
was in the range of $50,000 - $59,999 (range = $20,000 - $130,000+).  The average BMI 
percentile (BMI percentile) was 72nd percentile (SD = 25.1, range = 15 - 98) out of the 22 
participants.  Three (14%) out of the 22 participants had both a tonsillectomy and 
adenoidectomy.  For disease activity measures, the mean SLEDAI score was 5.27       
(SD = 5.04, range = 0 - 21) out of 22 participants and the mean sedimentation rate was 
28.7 (SD = 33.4, range = 1 - 106) out of 15 participants.  Of the 22 participants, 13 (59%) 
had kidney disease and 10 (45%) had central nervous system (CNS) involvement.   
 Table 5 lists a summary of the standard scores for all the questionnaire and 
cognitive testing variables for the SLE sample as a whole.  There were 22 families who 
completed the study questionnaires.  Seventeen of these 22 participants completed the 
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cognitive testing measures.  The means for the obstructive sleep apnea (OSA), Global 
Executive Composite, Category Switching Number Correct, Verbal Fluency Set-Loss 
Errors, Verbal Fluency Repetition Errors, Letter-Number Sequencing, Letter-Number 
Sequencing Errors, and Digit Span scores were 101.5 (SD = 12.8, range = 86 - 132),   
98.5 (SD = 19.7, range = 79 - 146), 101.5 (SD = 12.3, range = 75 - 125), 110.0            
(SD = 7.91, range = 90 - 115), 96.8 (SD = 14.8, range = 55 - 110), 98.8 (SD = 20.4, 
range = 55 - 130), 105.0 (SD = 7.07, range = 85 - 110), and 100 (SD = 15.7,              
range = 80 - 145), respectively.  Table 5 lists the other subscale summary scores.  Table 6 
lists a summary of the scores in their original scoring format (i.e., t-scores, standard 
scores, scaled scores).  Fourteen percent met the criteria for the possibility of sleep-
disordered breathing on the OSA scale of the Sleep Disorders Inventory for Students.  On 
executive function measures, the following percentages show the prevalence rates of 
those with possible mild cognitive difficulties defined by those with scores in the low 
average to below low average range: Global Executive Composite = 14%, Category 
Switching Number Correct = 6%, Verbal Fluency Set-Loss Errors = 0%, Verbal Fluency 
Repetition Errors = 24%, Letter-Number Sequencing = 30%, Letter-Number Sequencing 
Errors = 6%, Digit Span = 18%, and IQ = 0%.  On the Depression scale, 19% had 
significant depressive symptoms. 
 Table 4 lists the demographic characteristics for the 24 participants selected as the 
control group.  Not all data were available for all participants; therefore, averages were 
calculated for the available data.  The average age of the 24 participants was 14.2 years 
(SD = 1.96 range = 9 - 17).  Out of the 24 participants, 15 (63%) were female and 9 
(37%) were male.  Out of the 24 participants, 7 (29%) were African American, 0 (0%) 
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were Asian, 1 (4%) was Caucasian, 15 (63%) were Hispanic, and 1 (4%) was identified 
as other indicating a different ethnicity.  Out of 17 of the participants, results from the 
Hollingshead Four Factor Index of Social Status indicated an average social class rating 
of 2 out of 5 (range = 1 - 4), which is the second lowest level.  Out of 20 of the 
participants, the average annual household income was in the $20,000 - $29,999 range 
(range = $0,000 - $59,999) and the median annual household income was in the $30,000 
- $39,999 range.  The average BMI percentile (BMI percentile) was 70th percentile      
(SD = 28.7, range = 9 - 99) out of 23 of the participants. Six (25%) out of the 24 
participants had tonsillectomies and 3 (13%) had adenoidectomies.  Table 5 lists a 
summary of the standard scores for the SDIS variables for the control group as a whole.  
The mean obstructive sleep apnea (OSA) score was 98.0 (SD = 11.9, range = 85 - 129).  
Table 6 lists a summary of the scores in their original scoring format (i.e., t-scores).  
Seventeen percent met the criteria for the possibility of sleep-disordered breathing on the 
OSA scale of the Sleep Disorders Inventory for Students (SDIS).   
The SLE group and selected control group were compared on age, socioeconomic 
status (income and Hollingshead), ethnicity, and gender to examine the equality of 
groups.  Results of an independent samples t-test indicated the SLE group (M = 15.5,    
SD = 2.70, N = 22) did not significantly differ in age from the control group (M = 14.2, 
SD = 1.96, N = 24; t [37.9] = -1.78, p = .083).  Results of an independent samples t-test 
indicated the SLE group (M = 6.82, SD = 3.28, N = 17) did significantly differ in income 
from the control group (M = 3.60, SD = 1.47, N = 20; t [21.4] = -3.74, p = .001.  Results 
of another independent samples t-test indicated the SLE group (M = 47.2, SD = 12.6,      
N = 19) did significantly differ on the Hollingshead from the control group (M = 22.2,   
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SD = 10.5, N = 17; t [34] = -6.42, p = .000).  Results of a Chi square analysis looking at 
gender indicated no association between SLE group/control group and gender                
(X2 [1, N = 46] = 1.18, p = .277).  Out of the 22 individuals in the SLE group, 77%         
(n = 17) were female, and out of 24 individuals in the control group, 63% (n = 15) were 
female.  Results of a Chi square analysis looking at ethnicity indicated an association 
between SLE group/control group and ethnicity (X2 [4, N = 46] = 13.9, p = .007).  Out of 
22 participants in the SLE group, 45% (n = 10) were African American and out of 24 
individuals in the control group, 29% (n = 7) were African American.  Results of an 
independent sample t-test indicated the SLE group (M = 72.3, SD = 25.1, N = 22) did not 
significantly differ in BMI percentile from the control group (M = 70.3, SD = 28.7,         
N = 23; t [43] = -.239, p = .812).  Results of a Chi square analysis looking at 
tonsillectomies indicated no association between SLE/control group and tonsillectomies 
(X2 [1, N = 46] =.942, p = .332).  Out of 22 participants in the SLE group, 14% (n = 3) 
had tonsillectomies and out of 24 individuals in the control group 25% (n = 6) had 
tonsillectomies.  Results of a Chi square analysis looking at adenoidectomies indicated no 
association between SLE/control group and adenoidectomies (X2 [1, N = 46] =.013,         
p = .909).  Out of 22 participants in the SLE group, 14% (n = 3) had tonsillectomies and 
out of 24 individuals in the control group 13% (n = 3) had tonsillectomies.  
 In the SLE group, those with and without central nervous system (CNS) 
involvement were compared on the study measures, by comparing the average standard 
scores.  Results of an independent samples t-test indicated those with CNS involvement 
had better standard scores on the Letter-Number Sequencing test (M = 112.9, SD = 9.51, 
N = 7) than those without CNS involvement (M = 89.0, SD = 20.4, N = 10; t [13] = -3.23, 
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p = .006), which is in the opposite direction than would be expected.  There were no 
differences between groups for the BRIEF Global Executive Composite, other 
paper/pencil cognitive test scores, Depression score, or OSA score.  In those with CNS 
involvement, 30% met the criteria for the possibility of sleep-disordered breathing on the 
OSA scale of the Sleep Disorders Inventory for Students, compared to 0% of those 
without CNS involvement.  On executive function measures, mild cognitive difficulties 
were defined by individuals with scores in the low average to below low average range.  
The following prevalence rates indicating possible mild cognitive difficulties were seen 
for CNS involvement versus no CNS involvement, respectively: Global Executive 
Composite = 10% versus 17%, Category Switching Number Correct = 0% versus 10%, 
Verbal Fluency Set-Loss Errors = 0% versus 0%, Verbal Fluency Repetition Errors = 
43% versus 10%, Letter-Number Sequencing = 0% versus 50%, Letter-Number 
Sequencing Errors = 0% versus 10%, Digit Span = 29% versus 10%, and IQ = 0% versus 
0%.  In those with CNS involvement, 20% had significant depressive symptoms, 
compared to 18% of those without CNS involvement. 
 
4.1.2 Sample representativeness 
For those with SLE, those who were included in the study were compared to those 
who were not included in this study.  Individuals were divided into 1) Group A (N = 22) 
made up of those who completed the questionnaires and/or testing and 2) Group B         
(N = 10) made up of those who were consented but did not complete any part of the study 
(n = 3), those who were not consented but agreed for us to contact them (n = 4), and those 
who declined to hear about the study (n = 3).  Information on gender, age, and ethnicity 
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was available for group comparison on all 32 individuals.  Results of an independent 
samples t-test indicated participants (M = 15.5, SD = 2.7, N = 22) did significantly differ 
in age from nonparticipants (M = 17.3, SD = 1.06, N = 10; t [29.7] = 2.77, p = .01).  
Results of a Chi square analysis looking at gender indicated no association between 
participants/nonparticipants and gender (X2 [1, N = 32] = .73, p = .393).  Out of 22 
participants, 77% (n = 17) were female, and out of 10 nonparticipants, 90% (n = 9) were 
female.  Results of a Chi square analysis looking at ethnicity indicated no association 
between participants/nonparticipants and ethnicity (X2 [4, N = 32] = 1.5, p = .827).  Out 
of 22 participants, 45% (n = 10) were African American, and out of 10 nonparticipants, 
30% (n = 3) were African American. 
For those with SLE included in the study, those who completed both the 
questionnaires and testing were compared to those who only completed the 
questionnaires.  Individuals were divided into 1) Group A (N = 17) made up of those who 
completed both the questionnaires and testing and 2) Group B (N = 5) made up of those 
who only completed the questionnaires.  Information on gender, age, ethnicity, 
socioeconomic status (income and Hollingshead), SLEDAI, CNS involvement, and 
kidney disease were available for group comparison.  Results of an independent samples 
t-test indicated test and questionnaire completers (M = 15.5, SD = 2.79, N = 17) did not 
significantly differ in age from questionnaire only completers (M = 15.2, SD = 2.68,       
N = 5; t [20] = -.234, p = .817).  Results of an independent samples t-test indicated test 
and questionnaire completers (M = 7.21, SD = 3.45, N = 14) did not significantly differ in 
income from questionnaire only completers (M = 5.00, SD = 1.73, N = 3; t [15] = -1.06,   
p = .304).  Results of an independent samples t-test indicated test and questionnaire 
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completers (M = 48.3, SD = 11.8, N = 16) did not significantly differ on the Hollingshead 
from questionnaire only completers (M = 41.3, SD = 18.0, N = 3; t [17] = -.865,               
p = .399).  Results of a Chi square analysis looking at gender indicated no association 
between test and questionnaire completers/questionnaire only completers and gender (X2 
[1, N = 22] = 1.90, p = .168).  Out of 17 test and questionnaire completers, 71% (n = 12) 
were female, and out of 5 questionnaire only completers, 100% (n = 5) were female.  
Results of a Chi square analysis looking at ethnicity indicated no association between test 
and questionnaire completers/questionnaire only completers and ethnicity (X2 [4, N = 22] 
= 8.19, p = .085).  Out of 17 test and questionnaire completers, 53% (n = 9) were African 
American, and out of 5 questionnaire only completers, 20% (n = 1) were African 
American.  Results of an independent samples t-test indicated test and questionnaire 
completers (M = 5.75, SD = 5.25, N = 17) did not significantly differ in SLEDAI score 
from questionnaire only completers (M = 3.60, SD = 4.34, N = 5; t [20] = -.837,               
p = .412).  Results of a Chi square analysis looking at CNS involvement indicated no 
association between test and questionnaire completers/questionnaire only completers and 
ethnicity (X2 [1, N = 22] = .552, p = .457).  Out of 17 test and questionnaire completers, 
41% (n = 7) had CNS involvement, and out of 5 questionnaire only completers, 60%      
(n = 3) had CNS involvement.  Results of a Chi square analysis looking at kidney disease 
indicated an association between test and questionnaire completers/questionnaire only 
completers and kidney disease (X2 [1, N = 22] = 4.09, p = .043).  Out of 17 test and 
questionnaire completers, 71% (n = 12) had kidney disease, and out of questionnaire only 
completers, 20% (n = 1) had kidney disease. 
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For non-SLE individuals, those selected as controls were compared to those who 
were not selected as controls.  Individuals were divided into 1) Group A (N = 24) made 
up of those who were selected to be in the control group and 2) Group B (N = 48) made 
up of those who completed the questionnaires but were not included in the control group.  
Information on gender, age, and ethnicity were available for group comparison.  Groups 
were also compared on the OSA scale.  Results of an independent samples t-test indicated 
controls (M = 14.2, SD = 1.96, N = 24) were significantly older in age than those not 
included as controls (M = 10.8, SD = 1.76, N = 47; t [69] = -7.40, p = .000).  Results of an 
independent samples t-test indicated controls (M = 3.60, SD = 1.47, N = 20) had a 
significantly higher income than those not included as controls (M = 2.59, SD = 1.71,     
N = 41; t [59] = -2.27, p = .027).  Results of an independent samples t-test indicated 
controls (M = 22.2, SD = 10.5, N = 17) did not significantly differ on the Hollingshead 
from those not included as controls (M = 20.8, SD = 10.3, N = 40; t [55] = -.476,              
p = .636).  Results of a Chi square analysis looking at gender indicated no association 
between controls/those not included as controls and gender (X2 [1, N = 72] = 3.37,           
p = .066).  Out of the 24 controls, 63% (n = 15) were female, and out of the 48 
individuals not included as controls, 40% (n = 19) were female.  Results of a Chi square 
analysis looking at ethnicity indicated no association between controls/those not included 
as controls and ethnicity (X2 [4, N = 72] = 1.02, p = .906).  Out of the controls, 30%        
(n = 7) were African American, and out of those not included as controls, 31% (n = 15) 
were African American.  Results of an independent samples t-test indicated controls      
(M = 98.0, SD = 11.9, N = 24) did not significantly differ on the OSA scale from those 
not included as controls (M = 103.6, SD = 15.7, N = 48; t [70] = 1.53, p = .131). 
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For non-SLE individuals, all those who completed the questionnaires were 
compared to those who did not complete the study questionnaires.  Individuals were 
divided into 1) Group A (N = 72) made up of those who were recruited and completed the 
questionnaires (i.e., this included both those selected and not selected as controls), and   
2) Group B (N = 26), nonparticipants, made up of individuals who were consented but 
did not return questionnaires (n = 17) and individuals who declined to hear about the 
study  (n = 9 out of 14; i.e., this included only the individuals who we had demographic 
information on).  Information on gender, age, and ethnicity was available for group 
comparison, although not on all individuals.  Results of an independent samples t-test 
indicated questionnaire completers (M = 11.9, SD = 2.43, N = 71) did not significantly 
differ in age from nonparticipants (M = 12.3, SD = 2.94, N = 25; t [94] = .61, p = .546).  
Results of a Chi square analysis looking at gender indicated an association between 
questionnaire completers/nonparticipants and gender (X2 [1, N = 98] = 6.81, p = .009).  
Out of 72 questionnaire completers, 47% (n = 34) were female, and out of 26 
nonparticipants, 77% (n = 20) were female.  Results of a Chi square analysis looking at 
ethnicity indicated an association between questionnaire completers/nonparticipants and 
ethnicity (X2 [4, N = 95] = 9.9, p = .041).  Out of 72 questionnaire completers, 30%        
(n = 22) were African American, and out of 24 nonparticipants, 67% (n = 16) were 
African American.  
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4.1.3 Description of data 
 The sampling distribution was examined for the SLE and control groups on the 
study variables.  For the SLE group, the variables examined included the Obstructive 
Sleep Apnea, Global Executive Composite, Category Switching Number Correct, Verbal 
Fluency Set-Loss Errors, Verbal Fluency Repetition Errors, Letter-Number Sequencing, 
Letter-Number Sequencing Errors, and Digit Span scores.  Statistical tests of normality 
including skewness and kurtosis, and investigation of histograms and quartiles, generally 
concluded the scales met the assumption of normality.  When applying the rules of 2x the 
standard error of kurtosis/skewness to assess for skewness/kurtosis, very mild elevations 
were seen.  For the control group, statistical tests of normality including skewness and 
kurtosis, and investigation of histograms and quartiles, revealed that the obstructive sleep 
apnea scale met the assumption of normality.   
 There were no missing data from paper/pencil measures used to assess cognition.  
The 17 participants completed all the cognitive testing measures.  For the questionnaires, 
one family of the group with SLE did not complete the depression measure.  For those 
who completed the questionnaires, there were a limited number of questions left blank, 
such that scores could be calculated without the missing question(s).  For some 
individuals, recent blood levels were not available within a three month period; therefore 
data was not included for those individuals.  Other information unavailable included 
weight, height, age, ethnicity, income, education, or employment information because the 
family member left out this information from the questionnaire.  Some of the information 
including weight, height, age, and ethnicity was obtainable through medical chart review, 
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but some information was still unattainable.  Therefore, individuals without this 
demographic information were left out of corresponding statistical analyses. 
For the SLE group, 13 (76%) were tested at home and 4 (24%) were tested in the 
clinic.  Results from independent samples t-tests indicated no difference on any of the 
primary study measures, whether children were tested at home or in the clinic.  For the 
SLE group, 10 (59%) were administered order A of the cognitive tests and 7 (42%) were 
administered order B.  There were no differences between those given administration 
order A or B on the main study measures.  Fourteen (82%) cognitive assessments were 
completed by the primary test assessor, two (12%) were conducted by two other assessors 
but with the primary assessor in the room providing supervision, and one (6%) 
assessment was conducted by one of these two other assessors without the in-room 
presence of the primary assessor.  There were no significant differences in cognitive 
testing results between those tested by the primary test assessor (N = 14) and those tested 
by the other assessors with or without the primary test assessor in the room (N = 3).   
 
4.2 Preliminary Analyses 
Since research indicates body mass index percentile (BMI percentile), age, and 
socioeconomic status are related to sleep-disordered breathing, preliminary correlation 
analyses looked at the association between the obstructive sleep apnea (OSA) score and 
these variables.  These analyses were conducted to see if these variables should be 
covaried for using an ANCOVA in the examination of Hypothesis 1.  Results from these 
analyses are listed in Table 7.  Results indicated that the OSA scale did not correlate with 
BMI percentile for the SLE sample (r = .20, p = .368, N = 22) nor for the control sample 
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(r = -.09, p = .660, N = 23).  The OSA scale did not correlate with age for the SLE 
sample (r = -.08, p = .731, N = 22) nor for the control sample (r = .04, p = .865, N = 24).  
There was no relationship between income and the OSA scale for the SLE sample          
(r = -.11, p = .669, N = 17) nor for the control sample (r = -.27, p = .259, N = 20).  There 
also was no relationship between the Hollingshead Four Factor Index of Social Status 
scale and the OSA scale for the SLE sample (r = -.12, p = .627, N = 19) nor for the 
control sample (r = -.03, p = .910, N = 17).  Therefore, none of these variables were 
included as covariates in the examination of Hypothesis 1. 
Since some children have adenoidectomies and/or tonsillectomies to help resolve 
sleep-disordered breathing, these variables were also assessed for use as covariates.  
Results from these analyses are listed in Table 7.  For the SLE group, there was a trend 
for a difference with those who did not have adenoidectomies having lower (i.e., better) 
OSA standard scores (M = 99.5, SD = 11.6, N = 19) than those who had adenoidectomies 
(M = 114, SD = 15.7, N = 3; t [20] = -1.94, p = .066).  The same individuals who had 
adenoidectomies also had tonsillectomies; therefore, statistical results were the same for 
the tonsillectomy analysis.  For the control group, there was no significant difference in 
OSA standard scores between those who did not have tonsillectomies (M = 96.2,          
SD = 10.8, N = 18) and those who had tonsillectomies (M = 103.7, SD = 14.6, N = 6);                
t [22] = -1.35, p = .190).  For the control group, there was also no difference in OSA 
standard scores between those who did not have adenoidectomies (M = 97.1, SD = 10.6, 
N = 21) and those individuals who had adenoidectomies (M = 104.3, SD = 21.6, N = 3);                
t [21] = -.568, p = .624).  Therefore, none of these variables were included as covariates 
in the examination of Hypothesis 1. 
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4.3 Examination of Hypotheses 
4.3.1 Hypothesis 1: Sleep-disordered breathing in the SLE group compared to the control 
group 
 
Hypothesis 1 stated that the SLE group would significantly differ in sleep-
disordered breathing from the control group.  The result for the main analysis for 
Hypothesis 1 is listed in Table 8 and can be seen in Figure 3.  An independent samples   
t-test examined the difference in sleep-disordered breathing by using group (SLE and 
Control) as the independent variable and the obstructive sleep apnea (OSA) scale as the 
dependent variable.  The analysis revealed that the mean score for the OSA scale for the 
SLE group (M = 101.5, SD = 12.8, N = 22) was not significantly different than the mean 
for the control group (M = 98.0, SD = 11.9, N = 24; t [44] = -.934, p = .356.  Although 
preliminary analyses indicated body mass index percentile, age, income, socioeconomic 
status, tonsillectomies, and adenoidectomies were not correlated with the OSA scale, 
additional ANCOVA analyses were still conducted to covary for these variables.  The 
ANCOVA analyses also concluded no difference between groups on the OSA scale.  
Hypothesis 1 was not supported. 
 
4.3.2 Hypothesis 2: The relationship between sleep-disordered breathing and executive 
functioning in the SLE group 
 
Hypothesis 2 stated that there would be a significant relationship between sleep-
disordered breathing and executive dysfunction in the SLE group.  Results for Hypothesis 
2 are listed in Table 9.  Sleep-disordered breathing was measured by the obstructive sleep 
apnea (OSA) scale.  Executive functioning was measured by the Global Executive 
Composite, Category Switching Number Correct, Verbal Fluency Set-Loss Errors, Verbal 
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Fluency Repetition Errors, Letter-Number Switching, Letter-Number Sequencing Errors, 
and Digit Span scores.  Results from correlation analyses between the OSA scale and the 
Global Executive Composite indicated a significant positive relationship (r = .47,            
p = .026, N = 22; see Figure 4).  There was a trend for a relationship between the OSA 
scale and the Verbal Fluency Repetition Errors score (r = -.49, p = .045, N = 17).  There 
were no significant relationships between the OSA scale and any of the other primary 
scales including the Category Switching Number Correct score (r = -.34, p = .188,          
N = 17), Verbal Fluency Set-Loss Errors score (r = -.08, p = .764, N = 17), Letter-
Number Sequencing score (r = .19, p = .459, N = 17), Letter-Number Sequencing Errors 
score (r = .29, p = .260, N = 17), nor the Digit Span score (r = -.13, p = .634, N = 17).  
Hypothesis 2 was supported by the Global Executive Composite scale, but not by the 
other measures of executive functioning.  
 
4.3.3 Hypothesis 3: An examination of risk factors in the relationship between sleep-
disordered breathing and executive functioning in the SLE group 
  
Hypothesis 3 stated that disease activity (i.e., Systemic Lupus Erythematosus 
Disease Activity Index, sedimentation rate) and disease severity (i.e., central nervous 
system involvement, kidney disease) would act as moderators, and depression would act 
as a mediator in the relationship between sleep-disordered breathing and executive 
dysfunction in SLE.  Due to the small sample size, these analyses were unable to be 
conducted in this study.  
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4.4 Exploratory Follow-up Analyses 
4.4.1 The relationship between the OSA scale and the other cognitive testing measures 
for the SLE group  
 
 Exploratory correlation analyses investigated any associations between the OSA 
scale and the other cognitive measures that were not used in the primary analyses.  Table 
9 contains a summary of the correlation analyses.  When the Behavior Rating Inventory 
of Executive Function Global Executive Composite scale was divided into the Behavior 
Regulation Index and Metacognition Index, the Metacognition Index remained 
significantly correlated with the OSA scale (r = .48, p = .024, N = 22) and the Behavior 
Regulation Index displayed a trend for a significant relationship with the OSA scale       
(r = .39, p = .066, N = 22).  Although there was a significant relationship between the 
Visual Scanning scale and the OSA scale (r = .57, p = .017, N = 17), this was in the 
opposite direction than would be expected.  The Motor Speed scale demonstrated a trend 
for a relationship with the OSA scale (r = .43, p = .089, N = 17), but this was also in the 
opposite direction than would be expected.  No other measures demonstrated significant 
relationships with the OSA scale (i.e., Letter Fluency, Category Fluency, Category 
Switching Accuracy, Number Sequencing, and Letter Sequencing).  
 
4.4.2 A comparison of other sleep scales between the SLE and control groups 
 Exploratory independent samples t-tests examined the occurrence of any 
differences in the average standard score on any other sleep scale between the SLE and 
control groups.  Results are listed in Table 8.  There were no significant differences 
between the SLE and Control groups on the other sleep scales (i.e., Periodic Limb 
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Movement, Delayed Sleep Phase Syndrome, Excessive Daytime Sleepiness, Narcolepsy, 
and Sleep Disturbance Index; see Figure 5).  According to the SDIS screening criteria, for 
the SLE sample, the possibility of excessive daytime sleepiness was 27%, periodic limb 
movement was 18%, delayed sleep phase syndrome was 32%, narcolepsy was 29%, and 
overall sleep disturbance was 22%.  For the control sample, the possibility of excessive 
daytime sleepiness was 13%, periodic limb movement was 4%, delayed sleep phase was 
21%, narcolepsy was 13%, and overall sleep disturbance was 13%.    
 
4.4.3 The relationship between the other sleep scales and the cognitive variables for the 
SLE group 
 
 Exploratory analyses examined any other relationships between the other sleep 
scales and the cognitive measures.  Results of the correlation analyses are listed in Table 
9.  For Periodic Limb Movement, there was a significant relationship with the Global 
Executive Composite (r = .66, p = .001, N = 22), and then subsequently the Behavior 
Regulation Index (r = .70, p = .000, N = 22) and Metacognition Index (r = .59, p = .004, 
N = 22).  There was also a trend for a relationship between the Periodic Limb Movement 
scale and the Letter Sequencing score (r = -.44, p = .076, N = 17).  For Delayed Sleep 
Phase Syndrome, there was a significant relationship with both the Number Sequencing 
score (r = -.69, p = .002, N = 17) and Letter Sequencing score (r = -.63, p = .007, N = 17).  
Trends for relationships were seen for Delayed Sleep Phase Syndrome with the Global 
Executive Composite (r = .42, p = .053, N = 22), Behavior Regulation Index (r = .38,      
p = .081, N = 22), and Metacognition Index (r = .41, p = .059, N = 22).  Excessive 
Daytime Sleepiness demonstrated significant relationships with the Global Executive 
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Composite (r = .66, p = .001, N = 22), Behavior Regulation Index (r = .67, p = .001,       
N = 22), Metacognition Index (r = .59, p = .003, N = 22), Number Sequencing (r = -.61,   
p = .009, N = 17), and Letter Sequencing (r = -.59, p = .011, N = 17).  The Narcolepsy 
scale showed a significant relationship with the Global Executive Composite (r = .56,     
p = .008, N = 21), Behavior Regulation Index (r = .58, p = .006, N = 21), Metacognition 
Index (r = .52, p = .017, N = 21), Number Sequencing (r = -.59, p = .015, N = 16), and 
Letter Sequencing (r = -.52, p = .038, N = 16) scores.  The Sleep Disturbance Index 
demonstrated significant relationships with the Global Executive Composite (r = .62,      
p = .002, N = 22), Behavior Regulation Index (r = .61, p = .002, N = 22), Metacognition 
Index (r = .58, p = .005, N = 22), Number Sequencing (r = -.55, p = .022, N = 17), and 
Letter Sequencing (r = -.52, p = .032, N = 17) scores.  
 
4.4.4 The relationship between the depression measure and the sleep and cognitive 
variables for the SLE group 
 
Exploratory analyses examined any relationships between the Depression score 
and the sleep and cognitive measures.  The Depression score demonstrated significant 
relationships with the Behavior Rating Inventory of Executive Function Global Executive 
Composite (r = .72, p = .000, N = 21), Behavior Regulation Index (r = .67, p = .001,       
N = 21), and Metacognition Index (r = .69, p = .001, N = 21) scores.  No other cognitive 
measures (i.e., DKEFS Verbal Fluency test scores, DKEFS Trail Making test scores, or 
WISC-IV/WAIS-III Digit Span score) demonstrated a significant relationship with the 
depression score.  The Depression score also demonstrated significant relationships with 
the Sleep Disorders Inventory for Students Obstructive Sleep Apnea scale (r = .49,          
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p = .021, N = 21), Periodic Limb Movement scale (r = .51, p = .018, N = 21), Excessive 
Daytime Sleepiness scale (r = .56, p = .008, N = 21), Narcolepsy scale (r = .51, p = .022, 
N = 21), and Sleep Disturbance Index scale (r = .53, p = .014, N = 21).  There was no 
significant relationship with the Depression score and the Delayed Sleep Phase Syndrome 
score (r = .25, p = .270, N = 21). 
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CHAPTER 5: DISCUSSION 
 
5.1 Overview of the Findings  
The purpose of this study was to determine if sleep-disordered breathing differed 
between children and adolescents with SLE compared to those without SLE.  This study 
also aimed to examine the relationship between sleep-disordered breathing and executive 
dysfunction in SLE, and examine risk factors that may contribute to this relationship.  
The goal was to provide information that would be helpful in identifying individuals with 
SLE who may be at risk for sleep-disordered breathing and, subsequently, cognitive 
problems.  
In sum, results from the main analyses indicated that individuals with SLE did not 
differ in sleep-disordered breathing symptoms from the control group.  Fourteen percent 
of the SLE group met criteria for the possibility of having sleep-disordered breathing on a 
parent-report questionnaire, compared to 17% of the control group.  In the SLE sample, 
an increase in symptoms of sleep-disordered breathing was related to an increase in 
executive function difficulties as measured by the BRIEF.  Risk factors that may have 
contributed to the relationship between sleep-disordered breathing and executive 
dysfunction were not examined because of the small sample size in this study.  
Exploratory follow-up analyses indicated no other subtypes of biologically based sleep 
problems (i.e., periodic limb movement, excessive daytime sleepiness, delayed sleep 
phase syndrome, narcolepsy, and overall sleep disturbance problems) compared to the 
control group.  However, relationships were seen with these other sleep problems and 
some executive functioning measures.  Exploratory analyses also indicated symptoms of 
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depression were related to some measures of cognitive and sleep functioning.  A 
discussion of the results, consistency of the results with heuristic sleep-disordered 
breathing models, limitations for this study, clinical implications, and ideas for future 
research, are discussed in detail in the sections below.  
 
5.2 Discussion of Hypotheses 
5.2.1 Hypothesis 1 
  The first hypothesis in this study examined parents report of sleep-disordered 
breathing in a sample of children and adolescents with SLE.  Participants were included 
if they met the diagnosis of SLE according to diagnostic criteria.  Based on the literature 
that indicates the involvement of immunoregulatory proteins in both SLE and in sleep-
disordered breathing (Alberti et al., 2003; Gabay et al., 1997; Lacki et al., 1997; Tauman 
et al., 2004), it was hypothesized that children and adolescents with SLE would differ in 
amount of sleep-disordered breathing symptoms compared to a control group. 
Specifically, those with SLE were thought to be at increased risk for sleep-disordered 
breathing.  The purpose of this examination was to add to the pediatric SLE literature on 
sleep functioning; an area scarcely studied in this population.  
The results from this study indicated that the children and adolescents with SLE 
did not exhibit more symptoms of sleep-disordered breathing than those without SLE on 
a parent-report measure.  These findings implied that sleep-disordered breathing was not 
a particular concern of these parents.  In general, the findings suggest that sleep-
disordered breathing is not a likely characteristic of SLE, as it may be in other pediatric 
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populations such as sickle cell disease, diabetes, ADHD, and spina bifida (Kirk et al., 
1999; Kothare et al., 2005; Owens, Maxim, et al., 2000; Villa et al., 2000).   
Although this statistical analysis had low power, was limited by a small SLE 
sample size, and had a low effect size, the means between the two groups were very 
close.  For the SLE sample, 14% met criteria for the possibility of sleep-disordered 
breathing on the Sleep Disorders Inventory for Students, which was similar to the control 
group of 17% meeting criteria.  When teasing out those with and without central nervous 
system (CNS) involvement no statistical difference was seen in the amount of sleep-
disordered breathing symptoms.  Interestingly, however, in those with CNS involvement, 
30% met the criteria for the possibility of sleep-disordered breathing on the Sleep 
Disorders Inventory for Students questionnaire, compared to 0% of those without CNS 
involvement.  These prevalence rates indicate the SLE sample as a whole is no different 
than non-SLE samples; however, CNS involvement may increase the risk of sleep-
disordered breathing.  
The findings from this analysis bring light to findings from other studies 
investigating sleep-disordered breathing in SLE.  Findings from this study are similar to 
results from the Cruz and colleagues (2007) study that investigated adolescents with SLE.  
Five participants from the current study were recruited from the same pediatric 
rheumatology clinic as the Cruz and colleagues (2007) study.  Both the Cruz and 
colleagues study and the current study were compared to separate control samples that 
were taken from the same pediatric ambulatory care clinic.  The study by Cruz and 
colleagues investigated roughly the same number of participants as the current study.  
The Childrens Sleep Habits Questionnaire, Sleep-Disordered Breathing scale, used in the 
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pilot study by Cruz and colleagues is reported to have unacceptable reliability (α = .51; 
Owens, Spirito, & McGuinn, 2000) and the subscale only includes three questions.  
However, when sleep problems were investigated with the more reliable Sleep Disorders 
Inventory for Students Obstructive Sleep Apnea scale (norming sample, α = .88  90; this 
studys SLE sample, α = 71) in this study, the SLE sample continued to show no 
difficulty in sleep-disordered breathing problems.  However, because questionnaires were 
used in both the current study and the Cruz and Colleagues study, reporter bias may have 
affected the results.   
Findings from the current study were contradictory to the findings by Valencia-
Flores and colleagues (1999) that suggested sleep problems occurred in their sample of 
adults with SLE as indicated by a polysomnography study.  The difference in sleep 
functioning may be related to age differences, in that disease severity and/or disease 
activity may not be as severe in younger individuals with SLE.  Furthermore, the authors 
did not indicate whether participants in this study had central nervous system (CNS) 
involvement.  Due to this studys limitations, polysomnography and actigraphy were 
unable to be performed.  More formally based evaluations of sleep-disordered breathing 
and sleep latency might have identified mild sleep-disordered breathing in this young 
population.  
 Interestingly, parents whose child had an adenoidectomy or tonsillectomy 
reported more problems with sleep-disordered breathing.  It is unclear whether the 
children in this sample had their adenoidectomies and tonsillectomies because of snoring 
and sleep problems, or because of other health or medical concerns.  Either way, having 
an adenoidectomy and/or tonsillectomy in this sample signified more sleep-disordered 
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breathing symptoms.  These parents may be more aware of their childs sleeping habits or 
their child may still have symptoms of sleep-disordered breathing despite their 
adenoidectomy and/or tonsillectomy. 
 
5.2.2 Hypothesis 2 
The second hypothesis in this study examined whether children and adolescents 
with SLE who exhibit increased sleep-disordered breathing symptoms have co-occurring 
executive functioning difficulties.  Based on pediatric literature and heuristic models 
(Archbold et al., 2004; Beebe, 2005; Beebe & Gozal, 2002; Beebe et al., 2004), it was 
hypothesized that there would be an association between sleep-disordered breathing and 
executive dysfunction in this studys sample of children and adolescents with SLE.    
Findings from this study indicated that the children and adolescents with SLE 
with more symptoms of sleep-disordered breathing on the Sleep Disorders Inventory for 
Students (SDIS) did have more executive functioning difficulties on the Behavior Rating 
Inventory of Executive Function (BRIEF).  Despite this relationship, it should be noted 
that most of the SLE sample scored within the average range on the BRIEF Global 
Executive Composite (GEC) score.  There was also more variability in the BRIEF GEC 
score at higher levels of the sleep-disordered breathing scale (i.e., OSA scale) of the 
SDIS.  This means these findings are based on a small sample of children and adolescents 
with more sleep-disordered breathing problems.  Analyses with other paper/pencil 
executive functioning measures did not indicate any significant associations.  Overall, 
findings from these analyses suggest that those children and adolescents with more sleep-
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disordered breathing symptoms may be more likely to have co-occurring executive 
functioning difficulties.  
It was interesting that the parent-report of executive function was associated with 
parent-report of sleep-disordered breathing, but paper/pencil tasks of executive function 
were not.  This may have occurred because parents may be better reporters of everyday 
functioning abilities.  In addition, the BRIEF is more of an assessment of 
neurobehavioral dysfunction, than the paper/pencil tasks.  Neurobehavioral dysfunction 
is what many researchers describe as problems for children and adolescents with sleep-
disordered breathing (Archbold et al., 2004; Beebe et al., 2004; Lewin et al., 2002).  
Some other studies have even found positive findings investigating sleep-disordered 
breathing and executive functioning by use of the BRIEF (Beebe et al., 2004).  However, 
because parents completed both the BRIEF and SDIS, parent report bias may account for 
this association.  Parents may be inaccurate reporters or may report more problems in 
hope to gain more services for their child.  There also was a difference in the sample size 
for the analyses.  For example, there were 22 participants included in the analysis looking 
at the relationship between the SDIS and the BRIEF.  There were 17 participants 
included in the analyses investigating the relationship between the SDIS and the 
paper/pencil testing measures.  Therefore, the sample size difference for the questionnaire 
versus paper/pencil testing analyses cannot be discounted as a reason for the difference in 
findings.  Furthermore, the paper/pencil tests may have capitalized on individual 
functions that may not have been specific enough to detect relationships.  In general, the 
BRIEF may be a better and quick measure to use to screen for executive functioning 
difficulties in SLE. 
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Previous research that has investigated cognitive functioning in children without 
SLE but with sleep-disordered breathing indicates these individuals have lower scores on 
executive functioning measures.  For example, studies have concluded these individuals 
have lower scores on measures of impulsivity, emotional control, self-initiation of 
activities, working memory, planning, organization, self-monitoring, verbal fluency, 
sustained attention, vigilance, mental flexibility, and visual attention skills (Archbold et 
al., 2004; Beebe et al., 2004).  The current study used correlation analyses to look at the 
relationship between sleep-disordered breathing and executive dysfunction.  Findings 
from this study are consistent with pediatric sleep-disordered breathing research and 
proposed heuristic models that suggest an association between sleep-disordered breathing 
and executive dysfunction.  
Interestingly, although previous research indicates children and adolescents with 
SLE have mild cognitive functioning difficulties (Papero et al., 1990; Wyckoff et al., 
1995), the SLE group in this study scored overall in the average range on all testing 
measures.  Prevalence rates for those with cognitive difficulties defined by scores in the 
low average to below low average range were fairly low.  These findings may have 
occurred because the SLE sample was from a middle class population, perhaps 
suggesting average cognitive abilities.  However, this studys sample had a similar 
socioeconomic status level, mean age, and number of participants to the Papero and 
colleagues (1990) study.  The Papero and colleagues study included 21 children with SLE 
with a mean age of 15 years, with no overt central nervous system involvement.  In the 
current study, 17 children were tested, 22 completed the questionnaire measures, and the 
mean age was also 15.  This study did not separate out those with overt central nervous 
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system (CNS) involvement, who you might suspect to have more executive functioning 
problems.  However, even with those individuals with CNS involvement included in this 
studys analyses, the overall sample scored in the average range on all study measures.  
When comparing those with and without CNS involvement, those with involvement did 
not demonstrate significantly poorer scores on the BRIEF or paper/pencil cognitive tests.  
Findings from the current study suggest that executive dysfunction is not an overall 
characteristic for children and adolescents with SLE as a group, but may be more of an 
individual concern.  
Another interesting difference between the current study and previous research 
findings is in intelligence.  A study by Wyckoff and colleagues (1995) indicated low 
average intellectual abilities.  The demographics of the Wyckoff and colleagues study 
was unavailable, therefore, it is unclear if this sample had lower intelligence because of a 
lower socioeconomic status, small sample size (i.e., eight participants), or if the results 
were true findings.  Interestingly, the overall score of intelligence from the current study 
sample was in the average range and is consistent with the findings from the Papero and 
colleagues (1990) study which had a sample of children from a similar socioeconomic 
status level as the current study.  Although the current study used an abbreviated measure 
of intelligence, this study had a much larger sample size than the Wyckoff and colleagues 
study and a roughly similar sample size as the Papero and colleagues study.  Findings 
suggest overall average intellectual abilities in children and adolescents with SLE as a 
group.  
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5.2.3 Hypothesis 3 
The third hypothesis intended to examine potential risk factors that might be 
specific to SLE and that may contribute to the relationship between sleep-disordered 
breathing and executive dysfunction in this population.  Based on a proposed heuristic 
sleep-disordered breathing model (Beebe, 2005), the current study hypothesized that 
disease activity (i.e., Systemic Lupus Erythematosus Disease Activity Index, 
sedimentation rate) and disease severity (i.e., central nervous system involvement, kidney 
disease) would moderate the relationship between sleep-disordered breathing and 
executive dysfunction in children and adolescents with SLE, and depression would 
mediate the relationship.  However, due to a small sample size the statistical analyses 
could not be conducted and this hypothesis could not be examined. 
  
5.3 Discussion of Exploratory Follow-up Analyses 
The first set of follow-up exploratory analyses investigated any associations 
between sleep-disordered breathing and any of the other cognitive functioning measures. 
These analyses were conducted to further evaluate the use of the cognitive screening 
measures in this study.  The findings indicated that individuals with SLE from this study 
displayed a significant relationship between scores on the sleep-disordered breathing 
scale and the Behavior Rating Inventory of Executive Function (BRIEF) Behavior 
Regulation Index and Metacognition Index.  As previously noted, reporter bias may be a 
possible reason for the association between these measures.  The small sample size also 
may affect the value of these results.  No other paper/pencil testing measures were 
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significantly related to sleep-disordered breathing.  Overall, the BRIEF continued to be a 
strong screening instrument for detecting executive functioning concerns. 
 The second set of follow-up exploratory analyses was conducted to further define 
sleep functioning in children and adolescents with SLE.  In this sample, there were no 
significant problems specific to the SLE group compared to the control group on the 
other sleep scales.  The findings indicated that compared to individuals without SLE, 
parents of children with SLE report that their children exhibit a relatively similar profile 
overall on scales measuring periodic limb movement, delayed sleep phase syndrome, 
excessive daytime sleepiness, narcolepsy, and overall sleep disturbance problems.  In 
fact, in this study, both children with SLE and without SLE scored in the overall non-
clinical range.  According to the Sleep Disorders Inventory for Students (SDIS) screening 
criteria, for the SLE sample, the possibility of excessive daytime sleepiness was 27%, 
periodic limb movement was 18%, delayed sleep phase syndrome was 32%, narcolepsy 
was 29%, and overall sleep disturbance was 22%.  Although a difference between groups 
was not evident, the control group showed a lower percentage of individuals with the 
possibility of these specific sleep problems.  For the control sample, the possibility of 
excessive daytime sleepiness was 10%, periodic limb movement was 11%, delayed sleep 
phase syndrome was 24%, narcolepsy was 14%, and overall sleep disturbance was 13%.  
This follow-up analysis suggests that although these specific biologically based sleep 
problems are not an area of overall significant concern for parents of young individuals 
with SLE, these individuals do tend to exhibit somewhat more sleep problems than those 
without SLE.  A larger sample size may have been able to better determine the small 
difference in these sleep functioning scores.  
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 The third set of exploratory analyses was conducted to determine if any of the 
other screening areas of sleep functioning were related to the screening areas of cognitive 
functioning.  Specifically, for periodic limb movement, there was a significant 
relationship with executive functioning measured by the BRIEF scales (i.e., Global 
Executive Composite, Behavior Regulation Index, and Metacognition Index).  For 
Delayed Sleep Phase Syndrome, there was a significant relationship with the Trail 
Making Number Sequencing and Trail Making Letter Sequencing tests, which are tests of 
visual processing speed.  For Excessive Daytime Sleepiness, there were significant 
relationships with the BRIEF scales (i.e., Global Executive Composite, Behavior 
Regulation Index, and Metacognition Index), as well as on visual processing speed 
measures including the Trail Making Number Sequencing and Trail Making Letter 
Sequencing.  For Narcolepsy, there was a relationship with the BRIEF scales (i.e., Global 
Executive Composite, Behavior Regulation Index, and Metacognition Index), as well as 
on the Trail Making Number Sequencing and Trail Making Letter Sequencing tests.  For 
the Sleep Disturbance Index, there was a significant relationship with the BRIEF scales 
(i.e., Global Executive Composite, Behavior Regulation Index, and Metacognition 
Index), as well as the Trail Making Number Sequencing and Trail Making Letter 
Sequencing tests.  As previously indicated in other analyses, reporter bias may be a 
possible reason for the association between the questionnaire measures.  These findings 
indicate that the BRIEF and paper/pencil tests of visual processing speed appeared to be 
the most successful screening measures, as indicated by their relationship with specific 
sleep problems.  
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The fourth set of exploratory analyses was conducted to explore any relationships 
between symptoms of depression and performance on sleep and cognitive functioning 
measures.  The findings indicated that the Depression scale from the Depression and 
Anxiety in Youth Scale (DAYS) did demonstrate significant relationships with the 
BRIEF scales (i.e., Global Executive Composite, Behavior Regulation Index, and 
Metacognition Index).  However, no other cognitive measures (i.e., DKEFS Verbal 
Fluency test scores, DKEFS Trail Making test scores, or WISC-IV/WAIS-III Digit Span 
score) demonstrated a significant relationship with the Depression scale.  The DAYS 
Depression score also demonstrated significant relationships with the SDIS Obstructive 
Sleep Apnea scale, Periodic Limb Movement, Excessive Daytime Sleepiness, 
Narcolepsy, and Sleep Disturbance Index scores.  There was no significant relationship 
between the Depression score and the Delayed Sleep Phase Syndrome score.  Reporter 
bias also applies to these findings as a possible reason for the association between these 
measures.  These findings suggest that children and adolescents with SLE with more 
symptoms of depression may be more likely to have executive functioning difficulties 
and sleep problems. 
 
5.4 Limitations 
There were several methodological limitations that may have limited the outcome 
and meaning of this studys findings.  The small sample size of the SLE group reduced 
the power for this studys statistical analyses.  The possible sample size was limited due 
to the age range.  Since only 15% to 20% of SLE cases are children, there were a limited 
number of individuals who could be recruited (McGhee et al., 2004; Stichweh et al., 
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2004).  Similar to other medical populations, illness-related factors such as flare-ups 
make it difficult for individuals with SLE to adhere to study appointments.  A larger 
sample size and more statistical power would have made it less likely of the probability 
of committing a type II error for Hypothesis 1.  A larger sample size would also have 
allowed for a more meaningful interpretation of Hypothesis 2, making for less variability 
in the BRIEF GEC score at higher levels of the SDIS OSA score.   
 The equality of the control group to the SLE sample in this study may have 
affected this studys ability to accurately describe sleep functioning in the SLE sample.  
The control group differed in ethnicity from the SLE group, with more Hispanics (63%) 
than African Americans (29%).  The SLE and control groups also differed in 
socioeconomic status, despite methodological procedures to develop an appropriate 
comparison group.  The difference in socioeconomic status and ethnicity likely occurred 
because more of the SLE sample came from The Childrens Hospital of Philadelphia 
which treats more of a middle class population, whereas the control group came from St. 
Christophers Hospital for Children which treats individuals from more of a lower 
socioeconomic status population.  Since lower socioeconomic status is associated with 
more sleep problems, the control group may have had more sleep symptoms than a 
socioeconomically matched control group.  Having a control group that was comparable 
in ethnicity and socioeconomic status would have made for a more appropriate 
comparison to help describe sleep functioning in SLE. 
The representativeness of the SLE sample may have limited this studys ability to 
generalize the results to the SLE population.  For example, only 45% of the SLE sample 
was African American, which is not consistent with the literature that indicates SLE 
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occurs more in the African American population (Hopkinson et al., 1994).  Relatively 
under control disease activity and mild disease severity in the SLE participants during 
their involvement in the study procedures, may also have made for a less representative 
sample.  There was a low disease activity level in this sample probably because study 
appointments were unable to be completed during disease flare-ups.  Additionally, 
disease activity measures were gathered through chart review, meaning disease activity 
levels may not have corresponded to the individuals disease activity level during 
measurement of cognitive and sleep functioning.  There was also mild disease severity in 
this sample.  Forty-five percent of the SLE sample had more severe disease as indicated 
by neuropsychiatric (i.e., CNS) involvement.  This is lower than indicated in the 
literature, which indicates between 48% and 95% of children with SLE have 
neuropsychiatric problems (Sibbitt et al., 2002; Steinlin et al., 1995).  Only 59% had 
kidney disease, compared to 67% to 82% reported in the literature (Cameron, 1994; 
Gibson, Ferris, Dooley, Huang, & Hogan, 2003; Klein-Gitelman et al., 2002).  Lower 
disease activity and mild disease severity may explain why the group overall had normal 
sleep and average cognitive abilities than have been reported in other studies.  A larger 
sample or different assessment procedures may have helped to incorporate more 
individuals with higher disease activity levels and more severe disease severity, and 
hence more possible functioning problems.  
 Parent report bias is always a question of concern in the pediatric literature and is 
especially a concern with adolescents.  Parents may be unaware of their adolescents sleep 
and behavioral functioning.  This may have led to an inaccurate documentation of sleep, 
behavioral, emotional, and cognitive abilities.  The use of adolescent self report in 
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conjunction with parent report may have provided a more accurate description of these 
abilities.  
The reliability of the Sleep Disorders Inventory for Students OSA scale may have 
affected this studys results.  Although the OSA subscale for the adolescent version of the 
questionnaire had respectable reliability for the SLE group, the subscale had undesirable 
reliability for the control group.  Since the reliability of the subscale with the adolescent 
control group was in the undesirable range, this may have affected the ability to 
accurately compare the sample groups.  The construction of the ethnic representation of 
the Sleep Disorders Inventory for Students was similar to the 2000 U.S. Census report.  
Therefore, a majority of the normative sample was Caucasian, which may have affected 
the results of this study since only 32% were Caucasian in the SLE group and 4% were 
Caucasian in the control group.  The socioeconomic status level reported for the 
normative data sample was in middle class range, which is similar to the SLE sample, but 
higher than the control group sample.   
Different measures of cognitive functioning were used in other studies in the 
pediatric SLE literature than were used in the current study.  Therefore the average 
cognitive abilities seen in this study may be evident because of test choice.  Many of the 
tests in this study measured working memory, cognitive flexibility, and processing speed.  
The addition of tests measuring other areas of executive functioning and cognitive 
abilities, such as problem solving, attention, vigilance, and complex working memory, 
may have been able to better describe which cognitive abilities are related to sleep-
disordered breathing in SLE.  
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5.5 Implications and Future Directions 
5.5.1 Clinical directions and implications 
Despite the many limitations that may have affected the results of this study, the 
main intent of this study was to provide further information regarding pediatric SLE for 
physicians, psychologists, patients, and caregivers.  The children and adolescents with 
SLE in this sample, as a group, were under relatively good disease activity, had mild 
disease severity, demonstrated a normal profile for sleep-disordered breathing compared 
to individuals without SLE, and demonstrated average intelligence and executive 
functioning skills.  Therefore, those with low disease activity and mild disease severity 
may be less susceptible to sleep and cognitive difficulties.   
Despite these normal profiles, during testing and speaking with the families, some 
patients and their parents did indicate the patient was having sleep problems and was 
sleepy during the day.  Sleep complaints consisted of difficulty falling asleep, difficulty 
staying asleep, and napping in the daytime.  In this SLE sample, there appeared to be a 
specific subset of participants who had more sleep and cognitive difficulties.  For 
example, 30% of individuals with central nervous system (CNS) involvement met the 
criteria for sleep-disordered breathing compared to 0% of those without CNS 
involvement according to the Sleep Disorders Inventory for Students (SDIS) 
questionnaire.  This was also the case with the other sleep scales (i.e., excessive daytime 
sleepiness, periodic limb movement, delayed sleep phase syndrome, narcolepsy, and 
overall sleep disturbance), with individuals with CNS involvement demonstrating more 
sleep problems than those without CNS involvement according to the SDIS 
questionnaire.  In addition, those with depressive symptoms tended to have more sleep 
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complaints (i.e., sleep-disordered breathing, periodic limb movement, excessive daytime 
sleepiness, and narcolepsy) and executive functioning difficulties as measured by the 
Behavior Rating Inventory of Executive Function (BRIEF).  Therefore, children and 
adolescents with SLE with these risk factors may be at increased risk for sleep and 
cognitive problems. 
One aim was to evaluate a potential screening battery for clinical use in 
determining any overall sleep or cognitive problems in this sample in order to provide 
these families with referrals for more comprehensive sleep or neuropsychological 
evaluations, if needed.  Results from this study suggest that the Sleep Disorders Inventory 
for Students (SDIS) and the Behavior Rating Inventory of Executive Function (BRIEF) 
may be adequate screening measures to assess for sleep and executive functioning 
concerns.  The Depression and Anxiety in Youth Scale (DAYS) depression subscale was 
also a reliable measure with this SLE sample.  The BRIEF, SDIS, and DAYS screening 
measures are easy to administer, quick for parents to complete, and require little training 
to administer and score.   
After children and adolescents are screened for any sleep, emotional, or cognitive 
problems, clinics should refer those individuals with problems for further evaluation.  
Those children who have more sleep problems would benefit from being referred on for a 
formal sleep evaluation including a polysomnography study.  Those children exhibiting 
cognitive problems would benefit from a comprehensive neuropsychological evaluation.  
The neuropsychological evaluation can assist with determining any areas of significant 
concerns regarding cognitive functioning, as well as provide referral information for 
services for school or outside of school.  Furthermore, psychotherapy, 
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psychopharmacological treatment, and monitoring of SLE inflammatory medications 
may be helpful in regulating depressive symptoms in this population. 
 
5.5.2 Research directions 
Although this sample of individuals with SLE did not demonstrate more 
symptoms of sleep-disordered breathing than a control sample, a relationship existed 
between sleep-disordered breathing and executive dysfunction.  Due to the small sample 
size, these results are preliminary, and future studies should be conducted that incorporate 
larger samples.  To increase participation, it will be important to employ multiple sites to 
obtain a larger set of eligible participants.  Collaborative efforts should be made with 
physicians and nurses to help in the identification and recruitment of eligible participants.  
Future studies may benefit from including participants who are 19 and 20 years old to 
increase the sample size, as many of those with SLE are not diagnosed until their teenage 
years.  To increase participation rates, studies may wish to incorporate a stipend to 
compensate for time spent participating in the study.  In this study, 88% of those that 
were consented completed the study measures that were offered the stipend from one 
hospital, compared to 40% who were not offered a stipend in the other hospital.  Home 
visits were also necessary and more successful for study completion.  However, the use 
of a full time research assistant who is available during each participants routine clinic 
visit and who can conduct home visits on a day to day basis may have an increased 
success rate with study completion. 
Future studies should investigate risk factors specific to this population that may 
contribute to the relationship between sleep-disordered breathing and executive 
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dysfunction as proposed by the pediatric sleep-disordered breathing heuristic model by 
Beebe (2005).  Although the current study could have considered conducting moderation 
and mediation analyses to examine risk and resilience factors, there was insufficient 
sample size for these analyses.  Therefore, future studies that incorporate larger samples 
could investigate the contribution of illness related factors in the relationship between 
sleep-disordered breathing and executive dysfunction in SLE.   
Future studies should devise ways to examine current disease activity levels 
during the time of the study procedures.  For example, adding a form of physician global 
assessment of disease activity by use of a Likert rating scale would be helpful.  The 
incorporation of a blood draw will allow for more accurate current disease activity 
information.  Since previous studies involving children and adults indicate that specific 
immunoregulatory proteins are involved in sleep-disordered breathing and in individuals 
with SLE (Alberti et al., 2003; Gabay et al., 1997; Lacki et al., 1997; Tauman et al., 
2004), inclusion of analyses involving immunoregulatory proteins in future studies will 
be important.  Examination of medication usage which may affect disease activity may 
also be helpful.  Including a review of MRI reports would help to confirm who to 
categorize as having more severe disease severity as indicated by CNS involvement.   
A more thorough evaluation of executive functioning skills including tasks 
assessing problem solving (e.g., Wisconsin Card Sorting Test, Category Test) and 
attention/vigilance (e.g., Conners Continuous Performance Test) would make for a more 
comprehensive and multimodal evaluation.  Furthermore, the addition of memory 
measures (e.g., Wide Range Assessment of Memory and Learning, Childrens Memory 
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Scale), could assess if sleeping problems are related to memory problems in this 
population.  A full neuropsychological assessment would be helpful in this process.   
Formal objective measures such as polysomnography and actigraphy might be 
useful in describing sleep functioning in SLE.  A polysomnography study may help to 
determine mild sleep difficulties not observable by parent report and would not be subject 
to report bias.  Specifically, researching a subset of children with central nervous system 
(CNS) involvement might be interesting, since findings from the current study indicted 
more of a prevalence of sleep-disordered breathing symptoms in those with CNS 
involvement.  Since many of the children and adolescents in this study complained of 
feeling sleepy and many of the adolescents indicated they were having a difficult time 
sleeping at night, actigraphy studies could better describe sleep latency in SLE.  
When using the Sleep Disorders Inventory for Students (Luginbuehl, 2006) 
questionnaire with the SLE population in research, it may be beneficial to look at the 
overall Sleep Disturbance Index score to obtain general sleep disturbance problems.  
Results from this study indicated the Sleep Disturbance Index score had excellent 
reliability.  However, since findings from exploratory analyses concluded there were mild 
elevations on some of the SDIS subscales (i.e., excessive daytime sleepiness, periodic 
limb movement, delayed sleep phase syndrome, and narcolepsy) compared to the control 
group and there were associations between these subscales and areas of executive 
functioning, further investigation of different areas of sleep disturbance may be 
interesting.   
This study used a control group for a more empirically based research design.  
However, the control group in this study only was administered the sleep functioning 
81 
 
questionnaire.  Future prospective studies should also use a control group for a 
comparison group for the cognitive functioning measures as well.  The control sample in 
this study differed in socioeconomic status from the SLE sample.  Therefore use of a 
sibling and/or matched peer control group in future studies may be a better comparison 
group.   
  
5.6 Conclusions 
 This study was one of the first to investigate sleep-disordered breathing and its 
association with executive functioning in children and adolescents with SLE.  One might 
postulate that individuals with SLE would be at increased risk for sleep-disordered 
breathing, because many of the same immunoregulatory proteins involved in SLE are 
also involved in those with sleep-disordered breathing.  In this study, children and 
adolescents with SLE did not show any more symptoms of sleep-disordered breathing 
than a sample without SLE.  However, individuals with SLE with more symptoms of 
sleep-disordered breathing did have more executive functioning difficulties.  Risk factors 
that may contribute to this relationship were unable to be examined because of the small 
sample size in this study.  This study was consistent with sleep heuristic models that 
propose a relationship between sleep-disordered breathing and executive dysfunction.  
This study advances our knowledge of SLE in children and adolescents.  The 
discussion covered the importance of screening for sleep, emotional, and cognitive 
functioning problems in this population.  The discussion highlighted the importance of 
providing referrals for a more comprehensive evaluation to those with sleep and cognitive 
problems.  This study also suggested how the Behavior Rating Inventory of Executive 
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Function (BRIEF), the Sleep Disorders Inventory for Students (SDIS), and the 
Depression and Anxiety in Youth Scale (DAYS), would be a useful set of screening 
measurements for identifying individuals in need of further evaluations and services.  
Given many methodological limitations, the findings from this study are preliminary.  
Further research is required that incorporates larger samples, a sibling or matched control 
group, and recent disease activity measurements to examine the questions in this study.  
Future research in pediatric SLE may also benefit from using a polysomnography study 
to investigate sleep functioning and a more comprehensive cognitive evaluation to assess 
executive functioning skills. 
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Figure 1: The Prefrontal Model. (Beebe & Gozal, 2002) 
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Figure 2: Heuristic Model of the Neurobehavioral Effects of Obstructive Sleep Apnea (OSA). 
(Beebe, 2005). 
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Figure 3: Mean Standard Scores for the OSA Scale by Group. 
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Figure 4: The Association between the BRIEF GEC Standard Score and SDIS OSA Standard 
Score. 
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